BindingDB Reactant_set_id	Ligand SMILES	Ligand InChI	Ligand InChI Key	BindingDB MonomerID	BindingDB Ligand Name	Target Name	Target Source Organism According to Curator or DataSource	Ki (nM)	IC50 (nM)	Kd (nM)	EC50 (nM)	kon (M-1-s-1)	koff (s-1)	pH	Temp (C)	Curation/DataSource	Article DOI	BindingDB Entry DOI	PMID	PubChem AID	Patent Number	Authors	Date of publication	Date in BindingDB	Institution	Link to Ligand in BindingDB	Link to Target in BindingDB	Link to Ligand-Target Pair in BindingDB	Ligand HET ID in PDB	PDB ID(s) for Ligand-Target Complex	PubChem CID	PubChem SID	ChEBI ID of Ligand	ChEMBL ID of Ligand	DrugBank ID of Ligand	IUPHAR_GRAC ID of Ligand	KEGG ID of Ligand	ZINC ID of Ligand	Number of Protein Chains in Target (>1 implies a multichain complex)	BindingDB Target Chain Sequence 1	PDB ID(s) of Target Chain 1	UniProt (SwissProt) Recommended Name of Target Chain 1	UniProt (SwissProt) Entry Name of Target Chain 1	UniProt (SwissProt) Primary ID of Target Chain 1	UniProt (SwissProt) Secondary ID(s) of Target Chain 1	UniProt (SwissProt) Alternative ID(s) of Target Chain 1	UniProt (TrEMBL) Submitted Name of Target Chain 1	UniProt (TrEMBL) Entry Name of Target Chain 1	UniProt (TrEMBL) Primary ID of Target Chain 1	UniProt (TrEMBL) Secondary ID(s) of Target Chain 1	UniProt (TrEMBL) Alternative ID(s) of Target Chain 1	BindingDB Target Chain Sequence 2	PDB ID(s) of Target Chain 2	UniProt (SwissProt) Recommended Name of Target Chain 2	UniProt (SwissProt) Entry Name of Target Chain 2	UniProt (SwissProt) Primary ID of Target Chain 2	UniProt (SwissProt) Secondary ID(s) of Target Chain 2	UniProt (SwissProt) Alternative ID(s) of Target Chain 2	UniProt (TrEMBL) Submitted Name of Target Chain 2	UniProt (TrEMBL) Entry Name of Target Chain 2	UniProt (TrEMBL) Primary ID of Target Chain 2	UniProt (TrEMBL) Secondary ID(s) of Target Chain 2	UniProt (TrEMBL) Alternative ID(s) of Target Chain 2	BindingDB Target Chain Sequence 3	PDB ID(s) of Target Chain 3	UniProt (SwissProt) Recommended Name of Target Chain 3	UniProt (SwissProt) Entry Name of Target Chain 3	UniProt (SwissProt) Primary ID of Target Chain 3	UniProt (SwissProt) Secondary ID(s) of Target Chain 3	UniProt (SwissProt) Alternative ID(s) of Target Chain 3	UniProt (TrEMBL) Submitted Name of Target Chain 3	UniProt (TrEMBL) Entry Name of Target Chain 3	UniProt (TrEMBL) Primary ID of Target Chain 3	UniProt (TrEMBL) Secondary ID(s) of Target Chain 3	UniProt (TrEMBL) Alternative ID(s) of Target Chain 3	BindingDB Target Chain Sequence 4	PDB ID(s) of Target Chain 4	UniProt (SwissProt) Recommended Name of Target Chain 4	UniProt (SwissProt) Entry Name of Target Chain 4	UniProt (SwissProt) Primary ID of Target Chain 4	UniProt (SwissProt) Secondary ID(s) of Target Chain 4	UniProt (SwissProt) Alternative ID(s) of Target Chain 4	UniProt (TrEMBL) Submitted Name of Target Chain 4	UniProt (TrEMBL) Entry Name of Target Chain 4	UniProt (TrEMBL) Primary ID of Target Chain 4	UniProt (TrEMBL) Secondary ID(s) of Target Chain 4	UniProt (TrEMBL) Alternative ID(s) of Target Chain 4	BindingDB Target Chain Sequence 5	PDB ID(s) of Target Chain 5	UniProt (SwissProt) Recommended Name of Target Chain 5	UniProt (SwissProt) Entry Name of Target Chain 5	UniProt (SwissProt) Primary ID of Target Chain 5	UniProt (SwissProt) Secondary ID(s) of Target Chain 5	UniProt (SwissProt) Alternative ID(s) of Target Chain 5	UniProt (TrEMBL) Submitted Name of Target Chain 5	UniProt (TrEMBL) Entry Name of Target Chain 5	UniProt (TrEMBL) Primary ID of Target Chain 5	UniProt (TrEMBL) Secondary ID(s) of Target Chain 5	UniProt (TrEMBL) Alternative ID(s) of Target Chain 5	BindingDB Target Chain Sequence 6	PDB ID(s) of Target Chain 6	UniProt (SwissProt) Recommended Name of Target Chain 6	UniProt (SwissProt) Entry Name of Target Chain 6	UniProt (SwissProt) Primary ID of Target Chain 6	UniProt (SwissProt) Secondary ID(s) of Target Chain 6	UniProt (SwissProt) Alternative ID(s) of Target Chain 6	UniProt (TrEMBL) Submitted Name of Target Chain 6	UniProt (TrEMBL) Entry Name of Target Chain 6	UniProt (TrEMBL) Primary ID of Target Chain 6	UniProt (TrEMBL) Secondary ID(s) of Target Chain 6	UniProt (TrEMBL) Alternative ID(s) of Target Chain 6	BindingDB Target Chain Sequence 7	PDB ID(s) of Target Chain 7	UniProt (SwissProt) Recommended Name of Target Chain 7	UniProt (SwissProt) Entry Name of Target Chain 7	UniProt (SwissProt) Primary ID of Target Chain 7	UniProt (SwissProt) Secondary ID(s) of Target Chain 7	UniProt (SwissProt) Alternative ID(s) of Target Chain 7	UniProt (TrEMBL) Submitted Name of Target Chain 7	UniProt (TrEMBL) Entry Name of Target Chain 7	UniProt (TrEMBL) Primary ID of Target Chain 7	UniProt (TrEMBL) Secondary ID(s) of Target Chain 7	UniProt (TrEMBL) Alternative ID(s) of Target Chain 7	BindingDB Target Chain Sequence 8	PDB ID(s) of Target Chain 8	UniProt (SwissProt) Recommended Name of Target Chain 8	UniProt (SwissProt) Entry Name of Target Chain 8	UniProt (SwissProt) Primary ID of Target Chain 8	UniProt (SwissProt) Secondary ID(s) of Target Chain 8	UniProt (SwissProt) Alternative ID(s) of Target Chain 8	UniProt (TrEMBL) Submitted Name of Target Chain 8	UniProt (TrEMBL) Entry Name of Target Chain 8	UniProt (TrEMBL) Primary ID of Target Chain 8	UniProt (TrEMBL) Secondary ID(s) of Target Chain 8	UniProt (TrEMBL) Alternative ID(s) of Target Chain 8	BindingDB Target Chain Sequence 9	PDB ID(s) of Target Chain 9	UniProt (SwissProt) Recommended Name of Target Chain 9	UniProt (SwissProt) Entry Name of Target Chain 9	UniProt (SwissProt) Primary ID of Target Chain 9	UniProt (SwissProt) Secondary ID(s) of Target Chain 9	UniProt (SwissProt) Alternative ID(s) of Target Chain 9	UniProt (TrEMBL) Submitted Name of Target Chain 9	UniProt (TrEMBL) Entry Name of Target Chain 9	UniProt (TrEMBL) Primary ID of Target Chain 9	UniProt (TrEMBL) Secondary ID(s) of Target Chain 9	UniProt (TrEMBL) Alternative ID(s) of Target Chain 9	BindingDB Target Chain Sequence 10	PDB ID(s) of Target Chain 10	UniProt (SwissProt) Recommended Name of Target Chain 10	UniProt (SwissProt) Entry Name of Target Chain 10	UniProt (SwissProt) Primary ID of Target Chain 10	UniProt (SwissProt) Secondary ID(s) of Target Chain 10	UniProt (SwissProt) Alternative ID(s) of Target Chain 10	UniProt (TrEMBL) Submitted Name of Target Chain 10	UniProt (TrEMBL) Entry Name of Target Chain 10	UniProt (TrEMBL) Primary ID of Target Chain 10	UniProt (TrEMBL) Secondary ID(s) of Target Chain 10	UniProt (TrEMBL) Alternative ID(s) of Target Chain 10	BindingDB Target Chain Sequence 11	PDB ID(s) of Target Chain 11	UniProt (SwissProt) Recommended Name of Target Chain 11	UniProt (SwissProt) Entry Name of Target Chain 11	UniProt (SwissProt) Primary ID of Target Chain 11	UniProt (SwissProt) Secondary ID(s) of Target Chain 11	UniProt (SwissProt) Alternative ID(s) of Target Chain 11	UniProt (TrEMBL) Submitted Name of Target Chain 11	UniProt (TrEMBL) Entry Name of Target Chain 11	UniProt (TrEMBL) Primary ID of Target Chain 11	UniProt (TrEMBL) Secondary ID(s) of Target Chain 11	UniProt (TrEMBL) Alternative ID(s) of Target Chain 11	BindingDB Target Chain Sequence 12	PDB ID(s) of Target Chain 12	UniProt (SwissProt) Recommended Name of Target Chain 12	UniProt (SwissProt) Entry Name of Target Chain 12	UniProt (SwissProt) Primary ID of Target Chain 12	UniProt (SwissProt) Secondary ID(s) of Target Chain 12	UniProt (SwissProt) Alternative ID(s) of Target Chain 12	UniProt (TrEMBL) Submitted Name of Target Chain 12	UniProt (TrEMBL) Entry Name of Target Chain 12	UniProt (TrEMBL) Primary ID of Target Chain 12	UniProt (TrEMBL) Secondary ID(s) of Target Chain 12	UniProt (TrEMBL) Alternative ID(s) of Target Chain 12	BindingDB Target Chain Sequence 13	PDB ID(s) of Target Chain 13	UniProt (SwissProt) Recommended Name of Target Chain 13	UniProt (SwissProt) Entry Name of Target Chain 13	UniProt (SwissProt) Primary ID of Target Chain 13	UniProt (SwissProt) Secondary ID(s) of Target Chain 13	UniProt (SwissProt) Alternative ID(s) of Target Chain 13	UniProt (TrEMBL) Submitted Name of Target Chain 13	UniProt (TrEMBL) Entry Name of Target Chain 13	UniProt (TrEMBL) Primary ID of Target Chain 13	UniProt (TrEMBL) Secondary ID(s) of Target Chain 13	UniProt (TrEMBL) Alternative ID(s) of Target Chain 13	BindingDB Target Chain Sequence 14	PDB ID(s) of Target Chain 14	UniProt (SwissProt) Recommended Name of Target Chain 14	UniProt (SwissProt) Entry Name of Target Chain 14	UniProt (SwissProt) Primary ID of Target Chain 14	UniProt (SwissProt) Secondary ID(s) of Target Chain 14	UniProt (SwissProt) Alternative ID(s) of Target Chain 14	UniProt (TrEMBL) Submitted Name of Target Chain 14	UniProt (TrEMBL) Entry Name of Target Chain 14	UniProt (TrEMBL) Primary ID of Target Chain 14	UniProt (TrEMBL) Secondary ID(s) of Target Chain 14	UniProt (TrEMBL) Alternative ID(s) of Target Chain 14	BindingDB Target Chain Sequence 15	PDB ID(s) of Target Chain 15	UniProt (SwissProt) Recommended Name of Target Chain 15	UniProt (SwissProt) Entry Name of Target Chain 15	UniProt (SwissProt) Primary ID of Target Chain 15	UniProt (SwissProt) Secondary ID(s) of Target Chain 15	UniProt (SwissProt) Alternative ID(s) of Target Chain 15	UniProt (TrEMBL) Submitted Name of Target Chain 15	UniProt (TrEMBL) Entry Name of Target Chain 15	UniProt (TrEMBL) Primary ID of Target Chain 15	UniProt (TrEMBL) Secondary ID(s) of Target Chain 15	UniProt (TrEMBL) Alternative ID(s) of Target Chain 15	BindingDB Target Chain Sequence 16	PDB ID(s) of Target Chain 16	UniProt (SwissProt) Recommended Name of Target Chain 16	UniProt (SwissProt) Entry Name of Target Chain 16	UniProt (SwissProt) Primary ID of Target Chain 16	UniProt (SwissProt) Secondary ID(s) of Target Chain 16	UniProt (SwissProt) Alternative ID(s) of Target Chain 16	UniProt (TrEMBL) Submitted Name of Target Chain 16	UniProt (TrEMBL) Entry Name of Target Chain 16	UniProt (TrEMBL) Primary ID of Target Chain 16	UniProt (TrEMBL) Secondary ID(s) of Target Chain 16	UniProt (TrEMBL) Alternative ID(s) of Target Chain 16	BindingDB Target Chain Sequence 17	PDB ID(s) of Target Chain 17	UniProt (SwissProt) Recommended Name of Target Chain 17	UniProt (SwissProt) Entry Name of Target Chain 17	UniProt (SwissProt) Primary ID of Target Chain 17	UniProt (SwissProt) Secondary ID(s) of Target Chain 17	UniProt (SwissProt) Alternative ID(s) of Target Chain 17	UniProt (TrEMBL) Submitted Name of Target Chain 17	UniProt (TrEMBL) Entry Name of Target Chain 17	UniProt (TrEMBL) Primary ID of Target Chain 17	UniProt (TrEMBL) Secondary ID(s) of Target Chain 17	UniProt (TrEMBL) Alternative ID(s) of Target Chain 17	BindingDB Target Chain Sequence 18	PDB ID(s) of Target Chain 18	UniProt (SwissProt) Recommended Name of Target Chain 18	UniProt (SwissProt) Entry Name of Target Chain 18	UniProt (SwissProt) Primary ID of Target Chain 18	UniProt (SwissProt) Secondary ID(s) of Target Chain 18	UniProt (SwissProt) Alternative ID(s) of Target Chain 18	UniProt (TrEMBL) Submitted Name of Target Chain 18	UniProt (TrEMBL) Entry Name of Target Chain 18	UniProt (TrEMBL) Primary ID of Target Chain 18	UniProt (TrEMBL) Secondary ID(s) of Target Chain 18	UniProt (TrEMBL) Alternative ID(s) of Target Chain 18	BindingDB Target Chain Sequence 19	PDB ID(s) of Target Chain 19	UniProt (SwissProt) Recommended Name of Target Chain 19	UniProt (SwissProt) Entry Name of Target Chain 19	UniProt (SwissProt) Primary ID of Target Chain 19	UniProt (SwissProt) Secondary ID(s) of Target Chain 19	UniProt (SwissProt) Alternative ID(s) of Target Chain 19	UniProt (TrEMBL) Submitted Name of Target Chain 19	UniProt (TrEMBL) Entry Name of Target Chain 19	UniProt (TrEMBL) Primary ID of Target Chain 19	UniProt (TrEMBL) Secondary ID(s) of Target Chain 19	UniProt (TrEMBL) Alternative ID(s) of Target Chain 19	BindingDB Target Chain Sequence 20	PDB ID(s) of Target Chain 20	UniProt (SwissProt) Recommended Name of Target Chain 20	UniProt (SwissProt) Entry Name of Target Chain 20	UniProt (SwissProt) Primary ID of Target Chain 20	UniProt (SwissProt) Secondary ID(s) of Target Chain 20	UniProt (SwissProt) Alternative ID(s) of Target Chain 20	UniProt (TrEMBL) Submitted Name of Target Chain 20	UniProt (TrEMBL) Entry Name of Target Chain 20	UniProt (TrEMBL) Primary ID of Target Chain 20	UniProt (TrEMBL) Secondary ID(s) of Target Chain 20	UniProt (TrEMBL) Alternative ID(s) of Target Chain 20	BindingDB Target Chain Sequence 21	PDB ID(s) of Target Chain 21	UniProt (SwissProt) Recommended Name of Target Chain 21	UniProt (SwissProt) Entry Name of Target Chain 21	UniProt (SwissProt) Primary ID of Target Chain 21	UniProt (SwissProt) Secondary ID(s) of Target Chain 21	UniProt (SwissProt) Alternative ID(s) of Target Chain 21	UniProt (TrEMBL) Submitted Name of Target Chain 21	UniProt (TrEMBL) Entry Name of Target Chain 21	UniProt (TrEMBL) Primary ID of Target Chain 21	UniProt (TrEMBL) Secondary ID(s) of Target Chain 21	UniProt (TrEMBL) Alternative ID(s) of Target Chain 21	BindingDB Target Chain Sequence 22	PDB ID(s) of Target Chain 22	UniProt (SwissProt) Recommended Name of Target Chain 22	UniProt (SwissProt) Entry Name of Target Chain 22	UniProt (SwissProt) Primary ID of Target Chain 22	UniProt (SwissProt) Secondary ID(s) of Target Chain 22	UniProt (SwissProt) Alternative ID(s) of Target Chain 22	UniProt (TrEMBL) Submitted Name of Target Chain 22	UniProt (TrEMBL) Entry Name of Target Chain 22	UniProt (TrEMBL) Primary ID of Target Chain 22	UniProt (TrEMBL) Secondary ID(s) of Target Chain 22	UniProt (TrEMBL) Alternative ID(s) of Target Chain 22	BindingDB Target Chain Sequence 23	PDB ID(s) of Target Chain 23	UniProt (SwissProt) Recommended Name of Target Chain 23	UniProt (SwissProt) Entry Name of Target Chain 23	UniProt (SwissProt) Primary ID of Target Chain 23	UniProt (SwissProt) Secondary ID(s) of Target Chain 23	UniProt (SwissProt) Alternative ID(s) of Target Chain 23	UniProt (TrEMBL) Submitted Name of Target Chain 23	UniProt (TrEMBL) Entry Name of Target Chain 23	UniProt (TrEMBL) Primary ID of Target Chain 23	UniProt (TrEMBL) Secondary ID(s) of Target Chain 23	UniProt (TrEMBL) Alternative ID(s) of Target Chain 23	BindingDB Target Chain Sequence 24	PDB ID(s) of Target Chain 24	UniProt (SwissProt) Recommended Name of Target Chain 24	UniProt (SwissProt) Entry Name of Target Chain 24	UniProt (SwissProt) Primary ID of Target Chain 24	UniProt (SwissProt) Secondary ID(s) of Target Chain 24	UniProt (SwissProt) Alternative ID(s) of Target Chain 24	UniProt (TrEMBL) Submitted Name of Target Chain 24	UniProt (TrEMBL) Entry Name of Target Chain 24	UniProt (TrEMBL) Primary ID of Target Chain 24	UniProt (TrEMBL) Secondary ID(s) of Target Chain 24	UniProt (TrEMBL) Alternative ID(s) of Target Chain 24	BindingDB Target Chain Sequence 25	PDB ID(s) of Target Chain 25	UniProt (SwissProt) Recommended Name of Target Chain 25	UniProt (SwissProt) Entry Name of Target Chain 25	UniProt (SwissProt) Primary ID of Target Chain 25	UniProt (SwissProt) Secondary ID(s) of Target Chain 25	UniProt (SwissProt) Alternative ID(s) of Target Chain 25	UniProt (TrEMBL) Submitted Name of Target Chain 25	UniProt (TrEMBL) Entry Name of Target Chain 25	UniProt (TrEMBL) Primary ID of Target Chain 25	UniProt (TrEMBL) Secondary ID(s) of Target Chain 25	UniProt (TrEMBL) Alternative ID(s) of Target Chain 25	BindingDB Target Chain Sequence 26	PDB ID(s) of Target Chain 26	UniProt (SwissProt) Recommended Name of Target Chain 26	UniProt (SwissProt) Entry Name of Target Chain 26	UniProt (SwissProt) Primary ID of Target Chain 26	UniProt (SwissProt) Secondary ID(s) of Target Chain 26	UniProt (SwissProt) Alternative ID(s) of Target Chain 26	UniProt (TrEMBL) Submitted Name of Target Chain 26	UniProt (TrEMBL) Entry Name of Target Chain 26	UniProt (TrEMBL) Primary ID of Target Chain 26	UniProt (TrEMBL) Secondary ID(s) of Target Chain 26	UniProt (TrEMBL) Alternative ID(s) of Target Chain 26	BindingDB Target Chain Sequence 27	PDB ID(s) of Target Chain 27	UniProt (SwissProt) Recommended Name of Target Chain 27	UniProt (SwissProt) Entry Name of Target Chain 27	UniProt (SwissProt) Primary ID of Target Chain 27	UniProt (SwissProt) Secondary ID(s) of Target Chain 27	UniProt (SwissProt) Alternative ID(s) of Target Chain 27	UniProt (TrEMBL) Submitted Name of Target Chain 27	UniProt (TrEMBL) Entry Name of Target Chain 27	UniProt (TrEMBL) Primary ID of Target Chain 27	UniProt (TrEMBL) Secondary ID(s) of Target Chain 27	UniProt (TrEMBL) Alternative ID(s) of Target Chain 27	BindingDB Target Chain Sequence 28	PDB ID(s) of Target Chain 28	UniProt (SwissProt) Recommended Name of Target Chain 28	UniProt (SwissProt) Entry Name of Target Chain 28	UniProt (SwissProt) Primary ID of Target Chain 28	UniProt (SwissProt) Secondary ID(s) of Target Chain 28	UniProt (SwissProt) Alternative ID(s) of Target Chain 28	UniProt (TrEMBL) Submitted Name of Target Chain 28	UniProt (TrEMBL) Entry Name of Target Chain 28	UniProt (TrEMBL) Primary ID of Target Chain 28	UniProt (TrEMBL) Secondary ID(s) of Target Chain 28	UniProt (TrEMBL) Alternative ID(s) of Target Chain 28	BindingDB Target Chain Sequence 29	PDB ID(s) of Target Chain 29	UniProt (SwissProt) Recommended Name of Target Chain 29	UniProt (SwissProt) Entry Name of Target Chain 29	UniProt (SwissProt) Primary ID of Target Chain 29	UniProt (SwissProt) Secondary ID(s) of Target Chain 29	UniProt (SwissProt) Alternative ID(s) of Target Chain 29	UniProt (TrEMBL) Submitted Name of Target Chain 29	UniProt (TrEMBL) Entry Name of Target Chain 29	UniProt (TrEMBL) Primary ID of Target Chain 29	UniProt (TrEMBL) Secondary ID(s) of Target Chain 29	UniProt (TrEMBL) Alternative ID(s) of Target Chain 29	BindingDB Target Chain Sequence 30	PDB ID(s) of Target Chain 30	UniProt (SwissProt) Recommended Name of Target Chain 30	UniProt (SwissProt) Entry Name of Target Chain 30	UniProt (SwissProt) Primary ID of Target Chain 30	UniProt (SwissProt) Secondary ID(s) of Target Chain 30	UniProt (SwissProt) Alternative ID(s) of Target Chain 30	UniProt (TrEMBL) Submitted Name of Target Chain 30	UniProt (TrEMBL) Entry Name of Target Chain 30	UniProt (TrEMBL) Primary ID of Target Chain 30	UniProt (TrEMBL) Secondary ID(s) of Target Chain 30	UniProt (TrEMBL) Alternative ID(s) of Target Chain 30	BindingDB Target Chain Sequence 31	PDB ID(s) of Target Chain 31	UniProt (SwissProt) Recommended Name of Target Chain 31	UniProt (SwissProt) Entry Name of Target Chain 31	UniProt (SwissProt) Primary ID of Target Chain 31	UniProt (SwissProt) Secondary ID(s) of Target Chain 31	UniProt (SwissProt) Alternative ID(s) of Target Chain 31	UniProt (TrEMBL) Submitted Name of Target Chain 31	UniProt (TrEMBL) Entry Name of Target Chain 31	UniProt (TrEMBL) Primary ID of Target Chain 31	UniProt (TrEMBL) Secondary ID(s) of Target Chain 31	UniProt (TrEMBL) Alternative ID(s) of Target Chain 31	BindingDB Target Chain Sequence 32	PDB ID(s) of Target Chain 32	UniProt (SwissProt) Recommended Name of Target Chain 32	UniProt (SwissProt) Entry Name of Target Chain 32	UniProt (SwissProt) Primary ID of Target Chain 32	UniProt (SwissProt) Secondary ID(s) of Target Chain 32	UniProt (SwissProt) Alternative ID(s) of Target Chain 32	UniProt (TrEMBL) Submitted Name of Target Chain 32	UniProt (TrEMBL) Entry Name of Target Chain 32	UniProt (TrEMBL) Primary ID of Target Chain 32	UniProt (TrEMBL) Secondary ID(s) of Target Chain 32	UniProt (TrEMBL) Alternative ID(s) of Target Chain 32	BindingDB Target Chain Sequence 33	PDB ID(s) of Target Chain 33	UniProt (SwissProt) Recommended Name of Target Chain 33	UniProt (SwissProt) Entry Name of Target Chain 33	UniProt (SwissProt) Primary ID of Target Chain 33	UniProt (SwissProt) Secondary ID(s) of Target Chain 33	UniProt (SwissProt) Alternative ID(s) of Target Chain 33	UniProt (TrEMBL) Submitted Name of Target Chain 33	UniProt (TrEMBL) Entry Name of Target Chain 33	UniProt (TrEMBL) Primary ID of Target Chain 33	UniProt (TrEMBL) Secondary ID(s) of Target Chain 33	UniProt (TrEMBL) Alternative ID(s) of Target Chain 33	BindingDB Target Chain Sequence 34	PDB ID(s) of Target Chain 34	UniProt (SwissProt) Recommended Name of Target Chain 34	UniProt (SwissProt) Entry Name of Target Chain 34	UniProt (SwissProt) Primary ID of Target Chain 34	UniProt (SwissProt) Secondary ID(s) of Target Chain 34	UniProt (SwissProt) Alternative ID(s) of Target Chain 34	UniProt (TrEMBL) Submitted Name of Target Chain 34	UniProt (TrEMBL) Entry Name of Target Chain 34	UniProt (TrEMBL) Primary ID of Target Chain 34	UniProt (TrEMBL) Secondary ID(s) of Target Chain 34	UniProt (TrEMBL) Alternative ID(s) of Target Chain 34	BindingDB Target Chain Sequence 35	PDB ID(s) of Target Chain 35	UniProt (SwissProt) Recommended Name of Target Chain 35	UniProt (SwissProt) Entry Name of Target Chain 35	UniProt (SwissProt) Primary ID of Target Chain 35	UniProt (SwissProt) Secondary ID(s) of Target Chain 35	UniProt (SwissProt) Alternative ID(s) of Target Chain 35	UniProt (TrEMBL) Submitted Name of Target Chain 35	UniProt (TrEMBL) Entry Name of Target Chain 35	UniProt (TrEMBL) Primary ID of Target Chain 35	UniProt (TrEMBL) Secondary ID(s) of Target Chain 35	UniProt (TrEMBL) Alternative ID(s) of Target Chain 35	BindingDB Target Chain Sequence 36	PDB ID(s) of Target Chain 36	UniProt (SwissProt) Recommended Name of Target Chain 36	UniProt (SwissProt) Entry Name of Target Chain 36	UniProt (SwissProt) Primary ID of Target Chain 36	UniProt (SwissProt) Secondary ID(s) of Target Chain 36	UniProt (SwissProt) Alternative ID(s) of Target Chain 36	UniProt (TrEMBL) Submitted Name of Target Chain 36	UniProt (TrEMBL) Entry Name of Target Chain 36	UniProt (TrEMBL) Primary ID of Target Chain 36	UniProt (TrEMBL) Secondary ID(s) of Target Chain 36	UniProt (TrEMBL) Alternative ID(s) of Target Chain 36	BindingDB Target Chain Sequence 37	PDB ID(s) of Target Chain 37	UniProt (SwissProt) Recommended Name of Target Chain 37	UniProt (SwissProt) Entry Name of Target Chain 37	UniProt (SwissProt) Primary ID of Target Chain 37	UniProt (SwissProt) Secondary ID(s) of Target Chain 37	UniProt (SwissProt) Alternative ID(s) of Target Chain 37	UniProt (TrEMBL) Submitted Name of Target Chain 37	UniProt (TrEMBL) Entry Name of Target Chain 37	UniProt (TrEMBL) Primary ID of Target Chain 37	UniProt (TrEMBL) Secondary ID(s) of Target Chain 37	UniProt (TrEMBL) Alternative ID(s) of Target Chain 37	BindingDB Target Chain Sequence 38	PDB ID(s) of Target Chain 38	UniProt (SwissProt) Recommended Name of Target Chain 38	UniProt (SwissProt) Entry Name of Target Chain 38	UniProt (SwissProt) Primary ID of Target Chain 38	UniProt (SwissProt) Secondary ID(s) of Target Chain 38	UniProt (SwissProt) Alternative ID(s) of Target Chain 38	UniProt (TrEMBL) Submitted Name of Target Chain 38	UniProt (TrEMBL) Entry Name of Target Chain 38	UniProt (TrEMBL) Primary ID of Target Chain 38	UniProt (TrEMBL) Secondary ID(s) of Target Chain 38	UniProt (TrEMBL) Alternative ID(s) of Target Chain 38	BindingDB Target Chain Sequence 39	PDB ID(s) of Target Chain 39	UniProt (SwissProt) Recommended Name of Target Chain 39	UniProt (SwissProt) Entry Name of Target Chain 39	UniProt (SwissProt) Primary ID of Target Chain 39	UniProt (SwissProt) Secondary ID(s) of Target Chain 39	UniProt (SwissProt) Alternative ID(s) of Target Chain 39	UniProt (TrEMBL) Submitted Name of Target Chain 39	UniProt (TrEMBL) Entry Name of Target Chain 39	UniProt (TrEMBL) Primary ID of Target Chain 39	UniProt (TrEMBL) Secondary ID(s) of Target Chain 39	UniProt (TrEMBL) Alternative ID(s) of Target Chain 39	BindingDB Target Chain Sequence 40	PDB ID(s) of Target Chain 40	UniProt (SwissProt) Recommended Name of Target Chain 40	UniProt (SwissProt) Entry Name of Target Chain 40	UniProt (SwissProt) Primary ID of Target Chain 40	UniProt (SwissProt) Secondary ID(s) of Target Chain 40	UniProt (SwissProt) Alternative ID(s) of Target Chain 40	UniProt (TrEMBL) Submitted Name of Target Chain 40	UniProt (TrEMBL) Entry Name of Target Chain 40	UniProt (TrEMBL) Primary ID of Target Chain 40	UniProt (TrEMBL) Secondary ID(s) of Target Chain 40	UniProt (TrEMBL) Alternative ID(s) of Target Chain 40	BindingDB Target Chain Sequence 41	PDB ID(s) of Target Chain 41	UniProt (SwissProt) Recommended Name of Target Chain 41	UniProt (SwissProt) Entry Name of Target Chain 41	UniProt (SwissProt) Primary ID of Target Chain 41	UniProt (SwissProt) Secondary ID(s) of Target Chain 41	UniProt (SwissProt) Alternative ID(s) of Target Chain 41	UniProt (TrEMBL) Submitted Name of Target Chain 41	UniProt (TrEMBL) Entry Name of Target Chain 41	UniProt (TrEMBL) Primary ID of Target Chain 41	UniProt (TrEMBL) Secondary ID(s) of Target Chain 41	UniProt (TrEMBL) Alternative ID(s) of Target Chain 41	BindingDB Target Chain Sequence 42	PDB ID(s) of Target Chain 42	UniProt (SwissProt) Recommended Name of Target Chain 42	UniProt (SwissProt) Entry Name of Target Chain 42	UniProt (SwissProt) Primary ID of Target Chain 42	UniProt (SwissProt) Secondary ID(s) of Target Chain 42	UniProt (SwissProt) Alternative ID(s) of Target Chain 42	UniProt (TrEMBL) Submitted Name of Target Chain 42	UniProt (TrEMBL) Entry Name of Target Chain 42	UniProt (TrEMBL) Primary ID of Target Chain 42	UniProt (TrEMBL) Secondary ID(s) of Target Chain 42	UniProt (TrEMBL) Alternative ID(s) of Target Chain 42	BindingDB Target Chain Sequence 43	PDB ID(s) of Target Chain 43	UniProt (SwissProt) Recommended Name of Target Chain 43	UniProt (SwissProt) Entry Name of Target Chain 43	UniProt (SwissProt) Primary ID of Target Chain 43	UniProt (SwissProt) Secondary ID(s) of Target Chain 43	UniProt (SwissProt) Alternative ID(s) of Target Chain 43	UniProt (TrEMBL) Submitted Name of Target Chain 43	UniProt (TrEMBL) Entry Name of Target Chain 43	UniProt (TrEMBL) Primary ID of Target Chain 43	UniProt (TrEMBL) Secondary ID(s) of Target Chain 43	UniProt (TrEMBL) Alternative ID(s) of Target Chain 43	BindingDB Target Chain Sequence 44	PDB ID(s) of Target Chain 44	UniProt (SwissProt) Recommended Name of Target Chain 44	UniProt (SwissProt) Entry Name of Target Chain 44	UniProt (SwissProt) Primary ID of Target Chain 44	UniProt (SwissProt) Secondary ID(s) of Target Chain 44	UniProt (SwissProt) Alternative ID(s) of Target Chain 44	UniProt (TrEMBL) Submitted Name of Target Chain 44	UniProt (TrEMBL) Entry Name of Target Chain 44	UniProt (TrEMBL) Primary ID of Target Chain 44	UniProt (TrEMBL) Secondary ID(s) of Target Chain 44	UniProt (TrEMBL) Alternative ID(s) of Target Chain 44	BindingDB Target Chain Sequence 45	PDB ID(s) of Target Chain 45	UniProt (SwissProt) Recommended Name of Target Chain 45	UniProt (SwissProt) Entry Name of Target Chain 45	UniProt (SwissProt) Primary ID of Target Chain 45	UniProt (SwissProt) Secondary ID(s) of Target Chain 45	UniProt (SwissProt) Alternative ID(s) of Target Chain 45	UniProt (TrEMBL) Submitted Name of Target Chain 45	UniProt (TrEMBL) Entry Name of Target Chain 45	UniProt (TrEMBL) Primary ID of Target Chain 45	UniProt (TrEMBL) Secondary ID(s) of Target Chain 45	UniProt (TrEMBL) Alternative ID(s) of Target Chain 45	BindingDB Target Chain Sequence 46	PDB ID(s) of Target Chain 46	UniProt (SwissProt) Recommended Name of Target Chain 46	UniProt (SwissProt) Entry Name of Target Chain 46	UniProt (SwissProt) Primary ID of Target Chain 46	UniProt (SwissProt) Secondary ID(s) of Target Chain 46	UniProt (SwissProt) Alternative ID(s) of Target Chain 46	UniProt (TrEMBL) Submitted Name of Target Chain 46	UniProt (TrEMBL) Entry Name of Target Chain 46	UniProt (TrEMBL) Primary ID of Target Chain 46	UniProt (TrEMBL) Secondary ID(s) of Target Chain 46	UniProt (TrEMBL) Alternative ID(s) of Target Chain 46	BindingDB Target Chain Sequence 47	PDB ID(s) of Target Chain 47	UniProt (SwissProt) Recommended Name of Target Chain 47	UniProt (SwissProt) Entry Name of Target Chain 47	UniProt (SwissProt) Primary ID of Target Chain 47	UniProt (SwissProt) Secondary ID(s) of Target Chain 47	UniProt (SwissProt) Alternative ID(s) of Target Chain 47	UniProt (TrEMBL) Submitted Name of Target Chain 47	UniProt (TrEMBL) Entry Name of Target Chain 47	UniProt (TrEMBL) Primary ID of Target Chain 47	UniProt (TrEMBL) Secondary ID(s) of Target Chain 47	UniProt (TrEMBL) Alternative ID(s) of Target Chain 47	BindingDB Target Chain Sequence 48	PDB ID(s) of Target Chain 48	UniProt (SwissProt) Recommended Name of Target Chain 48	UniProt (SwissProt) Entry Name of Target Chain 48	UniProt (SwissProt) Primary ID of Target Chain 48	UniProt (SwissProt) Secondary ID(s) of Target Chain 48	UniProt (SwissProt) Alternative ID(s) of Target Chain 48	UniProt (TrEMBL) Submitted Name of Target Chain 48	UniProt (TrEMBL) Entry Name of Target Chain 48	UniProt (TrEMBL) Primary ID of Target Chain 48	UniProt (TrEMBL) Secondary ID(s) of Target Chain 48	UniProt (TrEMBL) Alternative ID(s) of Target Chain 48	BindingDB Target Chain Sequence 49	PDB ID(s) of Target Chain 49	UniProt (SwissProt) Recommended Name of Target Chain 49	UniProt (SwissProt) Entry Name of Target Chain 49	UniProt (SwissProt) Primary ID of Target Chain 49	UniProt (SwissProt) Secondary ID(s) of Target Chain 49	UniProt (SwissProt) Alternative ID(s) of Target Chain 49	UniProt (TrEMBL) Submitted Name of Target Chain 49	UniProt (TrEMBL) Entry Name of Target Chain 49	UniProt (TrEMBL) Primary ID of Target Chain 49	UniProt (TrEMBL) Secondary ID(s) of Target Chain 49	UniProt (TrEMBL) Alternative ID(s) of Target Chain 49	BindingDB Target Chain Sequence 50	PDB ID(s) of Target Chain 50	UniProt (SwissProt) Recommended Name of Target Chain 50	UniProt (SwissProt) Entry Name of Target Chain 50	UniProt (SwissProt) Primary ID of Target Chain 50	UniProt (SwissProt) Secondary ID(s) of Target Chain 50	UniProt (SwissProt) Alternative ID(s) of Target Chain 50	UniProt (TrEMBL) Submitted Name of Target Chain 50	UniProt (TrEMBL) Entry Name of Target Chain 50	UniProt (TrEMBL) Primary ID of Target Chain 50	UniProt (TrEMBL) Secondary ID(s) of Target Chain 50	UniProt (TrEMBL) Alternative ID(s) of Target Chain 50
986853	COc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H16N6O7S/c1-22-10-5-8(12)14-3-15-9(5)17(16-10)11-7(19)6(18)4(24-11)2-23-25(13,20)21/h3-4,6-7,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,20,21)/t4-,6-,7-,11-/m1/s1	SVHOPJCSYNTLAH-RPKMEZRRSA-N	475937	US10865208, Compound I-1::[(2R,3S,4R,5R)-5-(4-amino-3-methoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475937	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475937&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501092	442076004							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986854	Cc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H16N6O6S/c1-4-6-9(12)14-3-15-10(6)17(16-4)11-8(19)7(18)5(23-11)2-22-24(13,20)21/h3,5,7-8,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,20,21)/t5-,7-,8-,11-/m1/s1	UZNNSZLBPUZAHJ-IOSLPCCCSA-N	475940	US10865208, Compound I-2::[(2R,3S,4R,5R)-5-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475940	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475940&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500658	442076007							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986855	CC(C)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O6S/c1-5(2)8-7-11(14)16-4-17-12(7)19(18-8)13-10(21)9(20)6(25-13)3-24-26(15,22)23/h4-6,9-10,13,20-21H,3H2,1-2H3,(H2,14,16,17)(H2,15,22,23)/t6-,9-,10-,13-/m1/s1	XLLGDESQDODKCI-ZRFIDHNTSA-N	475942	US10865208, Compound I-3::[(2R,3S,4R,5R)-5-(4-amino-3-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475942	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475942&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500867	442076009							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986856	Nc1ncnc2n(nc(COCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C18H22N6O7S/c19-16-13-11(7-29-6-10-4-2-1-3-5-10)23-24(17(13)22-9-21-16)18-15(26)14(25)12(31-18)8-30-32(20,27)28/h1-5,9,12,14-15,18,25-26H,6-8H2,(H2,19,21,22)(H2,20,27,28)/t12-,14-,15-,18-/m1/s1	FCFKVFKIDWFDRZ-SCFUHWHPSA-N	475943	US10865208, Compound I-4::[(2R,3S,4R,5R)-5-{4-amino-3-[(benzyloxy)methyl]-1H-pyrazolo[3,4-d]pyrimidin- 1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475943	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475943&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500732	442076010							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986857	CCOc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O7S/c1-2-23-11-6-9(13)15-4-16-10(6)18(17-11)12-8(20)7(19)5(25-12)3-24-26(14,21)22/h4-5,7-8,12,19-20H,2-3H2,1H3,(H2,13,15,16)(H2,14,21,22)/t5-,7-,8-,12-/m1/s1	FUGFBXZXIJOVKN-JTFADIMSSA-N	475944	US10865208, Compound I-5::[(2R,3S,4R,5R)-5-(4-amino-3-ethoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475944	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475944&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500692	442076011							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986858	CCc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O6S/c1-2-5-7-10(13)15-4-16-11(7)18(17-5)12-9(20)8(19)6(24-12)3-23-25(14,21)22/h4,6,8-9,12,19-20H,2-3H2,1H3,(H2,13,15,16)(H2,14,21,22)/t6-,8-,9-,12-/m1/s1	XBDKIUOKXYYQMJ-WOUKDFQISA-N	475945	US10865208, Compound I-6::[(2R,3S,4R,5R)-5-(4-amino-3-ethyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475945	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475945&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501263	442076012							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986859	CC(C)Oc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S/c1-5(2)25-12-7-10(14)16-4-17-11(7)19(18-12)13-9(21)8(20)6(26-13)3-24-27(15,22)23/h4-6,8-9,13,20-21H,3H2,1-2H3,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	YTSOHAFQBZXVSL-HTVVRFAVSA-N	475946	US10865208, Compound I-7::[(2R,3S,4R,5R)-5-(4-amino-3-isopropoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475946	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475946&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500700	442076013							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986860	Nc1ncnc2n(nc(CO)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H16N6O7S/c12-9-6-4(1-18)16-17(10(6)15-3-14-9)11-8(20)7(19)5(24-11)2-23-25(13,21)22/h3,5,7-8,11,18-20H,1-2H2,(H2,12,14,15)(H2,13,21,22)/t5-,7-,8-,11-/m1/s1	ZJCLGSUMYSKODM-IOSLPCCCSA-N	475947	US10865208, Compound I-8::{(2R,3S,4R,5R)-5-[4-amino-3-(hydroxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475947	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475947&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501221	442076014							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986861	Nc1ncnc2n(nc(C#C)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H14N6O6S/c1-2-5-7-10(13)15-4-16-11(7)18(17-5)12-9(20)8(19)6(24-12)3-23-25(14,21)22/h1,4,6,8-9,12,19-20H,3H2,(H2,13,15,16)(H2,14,21,22)/t6-,8-,9-,12-/m1/s1	YGDMANQLVYBPFW-WOUKDFQISA-N	475949	US10865208, Compound I-9::[(2R,3S,4R,5R)-5-(4-amino-3-ethynyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475949	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475949&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500783	442076016							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986862	Nc1ncnc2n(nc(c12)C(F)(F)F)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H13F3N6O6S/c12-11(13,14)7-4-8(15)17-2-18-9(4)20(19-7)10-6(22)5(21)3(26-10)1-25-27(16,23)24/h2-3,5-6,10,21-22H,1H2,(H2,15,17,18)(H2,16,23,24)/t3-,5-,6-,10-/m1/s1	YQIQYAANVFHQLX-BHBWVORQSA-N	475950	US10865208, Compound I-10::{(2R,3S,4R,5R)-5-[4-amino-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475950	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475950&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501227	442076017							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986863	COCC#Cc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C14H18N6O7S/c1-25-4-2-3-7-9-12(15)17-6-18-13(9)20(19-7)14-11(22)10(21)8(27-14)5-26-28(16,23)24/h6,8,10-11,14,21-22H,4-5H2,1H3,(H2,15,17,18)(H2,16,23,24)/t8-,10-,11-,14-/m1/s1	NFLCXPYRVZSRNK-IDTAVKCVSA-N	475951	US10865208, Compound I-11::{(2R,3S,4R,5R)-5-[4-amino-3-(3-methoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475951	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475951&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500760	442076018							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986864	Nc1ncnc2n(nc(CCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C18H22N6O6S/c19-16-13-11(7-6-10-4-2-1-3-5-10)23-24(17(13)22-9-21-16)18-15(26)14(25)12(30-18)8-29-31(20,27)28/h1-5,9,12,14-15,18,25-26H,6-8H2,(H2,19,21,22)(H2,20,27,28)/t12-,14-,15-,18-/m1/s1	WEYQHDMGURKOGT-SCFUHWHPSA-N	475953	US10865208, Compound I-12::{(2R,3S,4R,5R)-5-[4-amino-3-(2-phenylethyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475953	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475953&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500748	442076020							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986865	Nc1ncnc2n(nc(C#N)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H13N7O6S/c12-1-4-6-9(13)15-3-16-10(6)18(17-4)11-8(20)7(19)5(24-11)2-23-25(14,21)22/h3,5,7-8,11,19-20H,2H2,(H2,13,15,16)(H2,14,21,22)/t5-,7-,8-,11-/m1/s1	HUZISIMTERHADL-IOSLPCCCSA-N	475954	US10865208, Compound I-13::[(2R,3S,4R,5R)-5-(4-amino-3-cyano-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475954	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475954&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500716	442076021							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986866	CC#Cc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H16N6O6S/c1-2-3-6-8-11(14)16-5-17-12(8)19(18-6)13-10(21)9(20)7(25-13)4-24-26(15,22)23/h5,7,9-10,13,20-21H,4H2,1H3,(H2,14,16,17)(H2,15,22,23)/t7-,9-,10-,13-/m1/s1	ONHKSEPHDMQFQH-QYVSTXNMSA-N	475955	US10865208, Compound I-14::{(2R,3S,4R,5R)-5-[4-amino-3 -(prop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475955	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475955&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151355013	442076022							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986867	NCc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H17N7O6S/c12-1-4-6-9(13)15-3-16-10(6)18(17-4)11-8(20)7(19)5(24-11)2-23-25(14,21)22/h3,5,7-8,11,19-20H,1-2,12H2,(H2,13,15,16)(H2,14,21,22)/t5-,7-,8-,11-/m1/s1	HOSDCTWWUOKOPW-IOSLPCCCSA-N	475956	US10865208, Compound I-15::{(2R,3S,4R,5R)-5-[4-amino-3-(aminomethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475956	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475956&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500428	442076023							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986868	NC(=O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H15N7O7S/c12-8-4-5(9(13)21)17-18(10(4)16-2-15-8)11-7(20)6(19)3(25-11)1-24-26(14,22)23/h2-3,6-7,11,19-20H,1H2,(H2,13,21)(H2,12,15,16)(H2,14,22,23)/t3-,6-,7-,11-/m1/s1	UZDAADDQDYMFTO-BBBNYMBOSA-N	475957	US10865208, Compound I-16::[(2R,3S,4R,5R)-5-(4-amino-3-carbamoyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475957	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475957&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500755	442076024							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986869	NCC#Cc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H17N7O6S/c14-3-1-2-6-8-11(15)17-5-18-12(8)20(19-6)13-10(22)9(21)7(26-13)4-25-27(16,23)24/h5,7,9-10,13,21-22H,3-4,14H2,(H2,15,17,18)(H2,16,23,24)/t7-,9-,10-,13-/m1/s1	KRIYPSTUCUSLGI-QYVSTXNMSA-N	475958	US10865208, Compound I-17::{(2R,3S,4R,5R)-5-[4-amino-3-(3-aminoprop-1-yn-1-yl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475958	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475958&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501132	442076025							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986870	Nc1ncnc2n(nc(C=C)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H16N6O6S/c1-2-5-7-10(13)15-4-16-11(7)18(17-5)12-9(20)8(19)6(24-12)3-23-25(14,21)22/h2,4,6,8-9,12,19-20H,1,3H2,(H2,13,15,16)(H2,14,21,22)/t6-,8-,9-,12-/m1/s1	BONWUYUHOXPHBH-WOUKDFQISA-N	475959	US10865208, Compound I-18::[(2R,3S,4R,5R)-5-(4-amino-3-vinyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475959	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475959&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295301	442076026							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986871	COCc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O7S/c1-23-2-5-7-10(13)15-4-16-11(7)18(17-5)12-9(20)8(19)6(25-12)3-24-26(14,21)22/h4,6,8-9,12,19-20H,2-3H2,1H3,(H2,13,15,16)(H2,14,21,22)/t6-,8-,9-,12-/m1/s1	RAWNPQRYXIHMNE-WOUKDFQISA-N	475960	US10865208, Compound I-19::{(2R,3S,4R,5R)-5-[4-amino-3-(methoxymethyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475960	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475960&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500720	442076027							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986872	COC(=O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H16N6O8S/c1-24-12(21)6-5-9(13)15-3-16-10(5)18(17-6)11-8(20)7(19)4(26-11)2-25-27(14,22)23/h3-4,7-8,11,19-20H,2H2,1H3,(H2,13,15,16)(H2,14,22,23)/t4-,7-,8-,11-/m1/s1	RMJQRYXNLIWVFQ-TZQXKBMNSA-N	475961	US10865208, Compound I-20::methyl 4-amino-1-{(2R,3R,4S,5R)-3,4-dihydroxy-5- [(sulfamoyloxy)methyl]tetrahydrofuran-2-yl}-1H-pyrazolo[3,4-d]pyrimidine-3- carboxylate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475961	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475961&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501476	442076028							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986873	CC(=O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H16N6O7S/c1-4(19)7-6-10(13)15-3-16-11(6)18(17-7)12-9(21)8(20)5(25-12)2-24-26(14,22)23/h3,5,8-9,12,20-21H,2H2,1H3,(H2,13,15,16)(H2,14,22,23)/t5-,8-,9-,12-/m1/s1	MQSGTFKZHPNPAT-JJNLEZRASA-N	475962	US10865208, Compound I-21::[(2R,3S,4R,5R)-5-(3-acetyl-4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475962	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475962&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148533348	442076029							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986874	COC(C)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S/c1-5(24-2)8-7-11(14)16-4-17-12(7)19(18-8)13-10(21)9(20)6(26-13)3-25-27(15,22)23/h4-6,9-10,13,20-21H,3H2,1-2H3,(H2,14,16,17)(H2,15,22,23)/t5?,6-,9-,10-,13-/m1/s1	XIGHCNBVWDIZBS-DPXQIYNJSA-N	475963	US10865208, Compound I-22::[(2R,3S,4R,5R)-5-{4-amino-3-[(1R)-1-methoxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate and [(2R,3S,4R,5R)-5-{4-amino-3-[(1S)-1-methoxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475963	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475963&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295299	442076030							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986875	CC(O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@H](O)[C@@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O7S/c1-4(19)7-6-10(13)15-3-16-11(6)18(17-7)12-9(21)8(20)5(25-12)2-24-26(14,22)23/h3-5,8-9,12,19-21H,2H2,1H3,(H2,13,15,16)(H2,14,22,23)/t4?,5-,8+,9+,12-/m1/s1	TVOCSXIMZVTDKB-HANPSPKASA-N	475964	US10865208, Compound I-23b::[(2R,3S,4R,5R)-5-{4-amino-3-[(1R)-1-hydroxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate or [(2R,3S,4R,5R)-5-{4-amino-3-[(1S)-1-hydroxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475964	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475964&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			156023127	442076031							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986876	CC(O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O7S/c1-4(19)7-6-10(13)15-3-16-11(6)18(17-7)12-9(21)8(20)5(25-12)2-24-26(14,22)23/h3-5,8-9,12,19-21H,2H2,1H3,(H2,13,15,16)(H2,14,22,23)/t4?,5-,8-,9-,12-/m1/s1	TVOCSXIMZVTDKB-LBGUGVGYSA-N	475965	US10865208, Compound I-23a::[(2R,3S,4R,5R)-5-{4-amino-3-[(1R)-1-hydroxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate or [(2R,3S,4R,5R)-5-{4-amino-3-[(1S)-1-hydroxyethyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475965	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475965&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295248	442076032							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986877	CC(C)(O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S/c1-13(2,22)9-6-10(14)16-4-17-11(6)19(18-9)12-8(21)7(20)5(26-12)3-25-27(15,23)24/h4-5,7-8,12,20-22H,3H2,1-2H3,(H2,14,16,17)(H2,15,23,24)/t5-,7-,8-,12-/m1/s1	QCTKHFCZUFKGHQ-JTFADIMSSA-N	475966	US10865208, Compound I-24::{(2R,3S,4R,5R)-5-[4-amino-3-(2-hydroxypropan-2-yl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475966	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475966&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500738	442076033							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986878	Nc1ncnc2n(nc(C(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H14F2N6O6S/c12-8(13)5-4-9(14)16-2-17-10(4)19(18-5)11-7(21)6(20)3(25-11)1-24-26(15,22)23/h2-3,6-8,11,20-21H,1H2,(H2,14,16,17)(H2,15,22,23)/t3-,6-,7-,11-/m1/s1	SSATVZDZRHXOIT-BBBNYMBOSA-N	475967	US10865208, Compound I-25::{(2R,3S,4R,5R)-5-[4-amino-3-(difluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475967	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475967&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501285	442076034							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986879	Nc1ncnc2n(nc(C3CC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H18N6O6S/c14-11-7-8(5-1-2-5)18-19(12(7)17-4-16-11)13-10(21)9(20)6(25-13)3-24-26(15,22)23/h4-6,9-10,13,20-21H,1-3H2,(H2,14,16,17)(H2,15,22,23)/t6-,9-,10-,13-/m1/s1	UGVXVBHQTRVSSD-ZRFIDHNTSA-N	475968	US10865208, Compound I-26::[(2R,3S,4R,5R)-5-(4-amino-3-cyclopropyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)- 3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475968	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475968&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295368	442076035							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986880	Nc1ncnc2n(nc(OC(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H14F2N6O7S/c12-11(13)26-9-4-7(14)16-2-17-8(4)19(18-9)10-6(21)5(20)3(25-10)1-24-27(15,22)23/h2-3,5-6,10-11,20-21H,1H2,(H2,14,16,17)(H2,15,22,23)/t3-,5-,6-,10-/m1/s1	DCMDVFZIMQIMKS-BHBWVORQSA-N	475969	US10865208, Compound I-27::{(2R,3S,4R,5R)-5-[4-amino-3-(difluoromethoxy)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475969	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475969&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500416	442076036							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986881	CC(C)(O)CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C14H22N6O7S2/c1-14(2,23)4-28-12-7-10(15)17-5-18-11(7)20(19-12)13-9(22)8(21)6(27-13)3-26-29(16,24)25/h5-6,8-9,13,21-23H,3-4H2,1-2H3,(H2,15,17,18)(H2,16,24,25)/t6-,8-,9-,13-/m1/s1	FBPQKTQQDYFTAW-HTVVRFAVSA-N	475970	US10865208, Compound I-28::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-hydroxy-2-methylpropyl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475970	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475970&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295430	442076037							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986882	Nc1ncnc2n(nc(CC#N)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H15N7O6S/c13-2-1-5-7-10(14)16-4-17-11(7)19(18-5)12-9(21)8(20)6(25-12)3-24-26(15,22)23/h4,6,8-9,12,20-21H,1,3H2,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,12-/m1/s1	CPQLSSHZWYSLBQ-WOUKDFQISA-N	475971	US10865208, Compound I-29::{(2R,3S,4R,5R)-5-[4-amino-3-(cyanomethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475971	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475971&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500764	442076038							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986883	Nc1ncnc2n(nc(-c3nccs3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H15N7O6S2/c14-10-6-7(12-16-1-2-27-12)19-20(11(6)18-4-17-10)13-9(22)8(21)5(26-13)3-25-28(15,23)24/h1-2,4-5,8-9,13,21-22H,3H2,(H2,14,17,18)(H2,15,23,24)/t5-,8-,9-,13-/m1/s1	KMKCZGVMUZGMLA-FITJORAGSA-N	475972	US10865208, Compound I-30::{(2R,3S,4R,5R)-5-[4-amino-3-(1,3-thiazol-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475972	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475972&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500776	442076039							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986884	Cc1cccc(CSc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1	InChI=1S/C18H22N6O6S2/c1-9-3-2-4-10(5-9)7-31-17-12-15(19)21-8-22-16(12)24(23-17)18-14(26)13(25)11(30-18)6-29-32(20,27)28/h2-5,8,11,13-14,18,25-26H,6-7H2,1H3,(H2,19,21,22)(H2,20,27,28)/t11-,13-,14-,18-/m1/s1	PTNSQSVAPXXLEQ-XWXWGSFUSA-N	475973	US10865208, Compound I-31::[(2R,3S,4R,5R)-5-{4-amino-3-[(3-methylbenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475973	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475973&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295280	442076040							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986885	Nc1ncnc2n(nc(SCc3ccc(OC(F)(F)F)cc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C18H19F3N6O7S2/c19-18(20,21)34-9-3-1-8(2-4-9)6-35-16-11-14(22)24-7-25-15(11)27(26-16)17-13(29)12(28)10(33-17)5-32-36(23,30)31/h1-4,7,10,12-13,17,28-29H,5-6H2,(H2,22,24,25)(H2,23,30,31)/t10-,12-,13-,17-/m1/s1	LTGPDOYDMXDULW-CNEMSGBDSA-N	475974	US10865208, Compound I-32::[(2R,3S,4R,5R)-5-(4-amino-3-{[4-(trifluoromethoxy)benzyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475974	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475974&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295431	442076041							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986886	Nc1ncnc2n(nc(SCc3ccc(cc3)C(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C18H19F3N6O6S2/c19-18(20,21)9-3-1-8(2-4-9)6-34-16-11-14(22)24-7-25-15(11)27(26-16)17-13(29)12(28)10(33-17)5-32-35(23,30)31/h1-4,7,10,12-13,17,28-29H,5-6H2,(H2,22,24,25)(H2,23,30,31)/t10-,12-,13-,17-/m1/s1	OMPKLIZZPBEVTO-CNEMSGBDSA-N	475975	US10865208, Compound I-33::[(2R,3S,4R,5R)-5-(4-amino-3-{[4-(trifluoromethyl)benzyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475975	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475975&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501356	442076042							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986887	Nc1ncnc2n(nc(Sc3ccc(Cl)cc3Cl)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H16Cl2N6O6S2/c17-6-1-2-9(7(18)3-6)31-15-10-13(19)21-5-22-14(10)24(23-15)16-12(26)11(25)8(30-16)4-29-32(20,27)28/h1-3,5,8,11-12,16,25-26H,4H2,(H2,19,21,22)(H2,20,27,28)/t8-,11-,12-,16-/m1/s1	KGMWWKKQDVUDMR-LKGUXBDMSA-N	475976	US10865208, Compound I-34::[(2R,3S,4R,5R)-5-{4-amino-3-[(2,4-dichlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475976	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475976&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501172	442076043							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986888	COCCSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S2/c1-24-2-3-27-12-7-10(14)16-5-17-11(7)19(18-12)13-9(21)8(20)6(26-13)4-25-28(15,22)23/h5-6,8-9,13,20-21H,2-4H2,1H3,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	CYSHGZLEBXGIPM-HTVVRFAVSA-N	475977	US10865208, Compound I-35::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-methoxyethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475977	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475977&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500908	442076044							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986889	Nc1ncnc2n(nc(Sc3cn[nH]c3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O			475978	US10865208, Compound I-36::{(2R,3S,4R,5R)-5-[4-amino-3-(1H-pyrazol-4-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475978	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475978&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500491	442076045							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986890	Nc1ncnc2n(nc(Oc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H18N6O7S/c17-13-10-14(20-7-19-13)22(21-15(10)28-8-4-2-1-3-5-8)16-12(24)11(23)9(29-16)6-27-30(18,25)26/h1-5,7,9,11-12,16,23-24H,6H2,(H2,17,19,20)(H2,18,25,26)/t9-,11-,12-,16-/m1/s1	OVVJELJLEMPMLR-UBEDBUPSSA-N	475979	US10865208, Compound I-37::[(2R,3S,4R,5R)-5-(4-amino-3-phenoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475979	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475979&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151397778	442076046							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986891	COc1ccc(CSc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1	InChI=1S/C18H22N6O7S2/c1-29-10-4-2-9(3-5-10)7-32-17-12-15(19)21-8-22-16(12)24(23-17)18-14(26)13(25)11(31-18)6-30-33(20,27)28/h2-5,8,11,13-14,18,25-26H,6-7H2,1H3,(H2,19,21,22)(H2,20,27,28)/t11-,13-,14-,18-/m1/s1	QKJMNAVDYGJJDQ-XWXWGSFUSA-N	475980	US10865208, Compound I-38::[(2R,3S,4R,5R)-5-{4-amino-3-[(4-methoxybenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475980	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475980&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295309	442076047							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986892	Cc1ccccc1CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C18H22N6O6S2/c1-9-4-2-3-5-10(9)7-31-17-12-15(19)21-8-22-16(12)24(23-17)18-14(26)13(25)11(30-18)6-29-32(20,27)28/h2-5,8,11,13-14,18,25-26H,6-7H2,1H3,(H2,19,21,22)(H2,20,27,28)/t11-,13-,14-,18-/m1/s1	JHRAAKUWKAUWJB-XWXWGSFUSA-N	475981	US10865208, Compound I-39::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-methylbenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475981	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475981&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295333	442076048							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986893	Nc1ncnc2n(nc(Sc3cccc(Cl)c3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H17ClN6O6S2/c17-7-2-1-3-8(4-7)30-15-10-13(18)20-6-21-14(10)23(22-15)16-12(25)11(24)9(29-16)5-28-31(19,26)27/h1-4,6,9,11-12,16,24-25H,5H2,(H2,18,20,21)(H2,19,26,27)/t9-,11-,12-,16-/m1/s1	LXYHPRCPJNVYDD-UBEDBUPSSA-N	475982	US10865208, Compound I-40::[(2R,3S,4R,5R)-5-{4-amino-3-[(3-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475982	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475982&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295437	442076049							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986894	Cc1ccc(CSc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1	InChI=1S/C18H22N6O6S2/c1-9-2-4-10(5-3-9)7-31-17-12-15(19)21-8-22-16(12)24(23-17)18-14(26)13(25)11(30-18)6-29-32(20,27)28/h2-5,8,11,13-14,18,25-26H,6-7H2,1H3,(H2,19,21,22)(H2,20,27,28)/t11-,13-,14-,18-/m1/s1	FIFQEXMDBCRMSP-XWXWGSFUSA-N	475983	US10865208, Compound I-41::[(2R,3S,4R,5R)-5-{4-amino-3-[(4-methylbenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475983	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475983&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295342	442076050							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986895	CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H16N6O6S2/c1-24-10-5-8(12)14-3-15-9(5)17(16-10)11-7(19)6(18)4(23-11)2-22-25(13,20)21/h3-4,6-7,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,20,21)/t4-,6-,7-,11-/m1/s1	KSULIUAOMXPISB-RPKMEZRRSA-N	475984	US10865208, Compound I-42::{(2R,3S,4R,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475984	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475984&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501222	442076051							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986896	Nc1ncnc2n(nc(SCC#C)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H16N6O6S2/c1-2-3-26-12-7-10(14)16-5-17-11(7)19(18-12)13-9(21)8(20)6(25-13)4-24-27(15,22)23/h1,5-6,8-9,13,20-21H,3-4H2,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	NSBCCFMDGXFNSZ-HTVVRFAVSA-N	475985	US10865208, Compound I-43::{(2R,3S,4R,5R)-5-[4-amino-3-(prop-2-yn-1-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475985	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475985&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295401	442076052							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986897	Nc1ncnc2n(nc(SCc3cccc(F)c3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H19FN6O6S2/c18-9-3-1-2-8(4-9)6-31-16-11-14(19)21-7-22-15(11)24(23-16)17-13(26)12(25)10(30-17)5-29-32(20,27)28/h1-4,7,10,12-13,17,25-26H,5-6H2,(H2,19,21,22)(H2,20,27,28)/t10-,12-,13-,17-/m1/s1	AJNWMZYCZCQGSA-CNEMSGBDSA-N	475986	US10865208, Compound I-44::[(2R,3S,4R,5R)-5-{4-amino-3-[(3-fluorobenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475986	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475986&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295352	442076053							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986898	Nc1ncnc2n(nc(SCc3cccnc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H19N7O6S2/c17-13-10-14(21-7-20-13)23(22-15(10)30-6-8-2-1-3-19-4-8)16-12(25)11(24)9(29-16)5-28-31(18,26)27/h1-4,7,9,11-12,16,24-25H,5-6H2,(H2,17,20,21)(H2,18,26,27)/t9-,11-,12-,16-/m1/s1	YVZDKQIGSFXLHJ-UBEDBUPSSA-N	475987	US10865208, Compound I-45::[(2R,3S,4R,5R)-5-{4-amino-3-[(pyridin-3-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475987	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475987&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295267	442076054							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986899	Nc1ncnc2n(nc(SCCO)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H18N6O7S2/c13-9-6-10(16-4-15-9)18(17-11(6)26-2-1-19)12-8(21)7(20)5(25-12)3-24-27(14,22)23/h4-5,7-8,12,19-21H,1-3H2,(H2,13,15,16)(H2,14,22,23)/t5-,7-,8-,12-/m1/s1	KNRHCLVQDNBXGN-JTFADIMSSA-N	475988	US10865208, Compound I-46::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-hydroxyethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475988	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475988&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295228	442076055							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986900	Nc1ncnc2n(nc(SC3CCCCC3O)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H24N6O7S2/c17-13-10-14(20-6-19-13)22(21-15(10)30-9-4-2-1-3-7(9)23)16-12(25)11(24)8(29-16)5-28-31(18,26)27/h6-9,11-12,16,23-25H,1-5H2,(H2,17,19,20)(H2,18,26,27)/t7?,8-,9?,11-,12-,16-/m1/s1	YGEVMDXWLMRLSF-CTVNXMRESA-N	475989	US10865208, Compound I-47::[(2R,3S,4R,5R)-5-(4-amino-3-{[(1R,2R)-2-hydroxycyclohexyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate and [(2R,3S,4R,5R)-5-(4-amino-3-{[(1S,2S)-2-hydroxycyclohexyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475989	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475989&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295418	442076056							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986901	Nc1ncnc2n(ncc12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C10H14N6O6S/c11-8-4-1-15-16(9(4)14-3-13-8)10-7(18)6(17)5(22-10)2-21-23(12,19)20/h1,3,5-7,10,17-18H,2H2,(H2,11,13,14)(H2,12,19,20)/t5-,6-,7-,10-/m1/s1	GDGSWPNRFYCUDB-DAGMQNCNSA-N	475990	US10865208, Compound I-48::[(2R,3S,4R,5R)-5-(4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475990	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475990&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501438	442076057							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986902	Nc1ncnc2n(nc(-c3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H18N6O6S/c17-14-10-11(8-4-2-1-3-5-8)21-22(15(10)20-7-19-14)16-13(24)12(23)9(28-16)6-27-29(18,25)26/h1-5,7,9,12-13,16,23-24H,6H2,(H2,17,19,20)(H2,18,25,26)/t9-,12-,13-,16-/m1/s1	LNVJDFSKZSJHOC-RVXWVPLUSA-N	475991	US10865208, Compound I-49::[(2R,3S,4R,5R)-5-(4-amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475991	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475991&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501343	442076058							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986903	Nc1ncnc2n(nc(SCC3CC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C14H20N6O6S2/c15-11-8-12(18-5-17-11)20(19-13(8)27-4-6-1-2-6)14-10(22)9(21)7(26-14)3-25-28(16,23)24/h5-7,9-10,14,21-22H,1-4H2,(H2,15,17,18)(H2,16,23,24)/t7-,9-,10-,14-/m1/s1	ZQRFGTMMIZACJL-AKAIJSEGSA-N	475992	US10865208, Compound I-50::[(2R,3S,4R,5R)-5-{4-amino-3-[(cyclopropylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475992	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475992&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295364	442076059							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986904	CCSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O6S2/c1-2-25-11-6-9(13)15-4-16-10(6)18(17-11)12-8(20)7(19)5(24-12)3-23-26(14,21)22/h4-5,7-8,12,19-20H,2-3H2,1H3,(H2,13,15,16)(H2,14,21,22)/t5-,7-,8-,12-/m1/s1	MINMBWMRXQZRGS-JTFADIMSSA-N	475993	US10865208, Compound I-51::{(2R,3S,4R,5R)-5-[4-amino-3-(ethylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475993	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475993&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151073050	442076060							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986905	Nc1ncnc2n(nc(SCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H20N6O6S2/c18-14-11-15(21-8-20-14)23(22-16(11)30-7-9-4-2-1-3-5-9)17-13(25)12(24)10(29-17)6-28-31(19,26)27/h1-5,8,10,12-13,17,24-25H,6-7H2,(H2,18,20,21)(H2,19,26,27)/t10-,12-,13-,17-/m1/s1	OJELGLQJHTUEFC-CNEMSGBDSA-N	475994	US10865208, Compound I-52::{(2R,3S,4R,5R)-5-[4-amino-3-(benzylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475994	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475994&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501334	442076061							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986906	CC(C)(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C14H22N6O6S2/c1-14(2,3)27-12-7-10(15)17-5-18-11(7)20(19-12)13-9(22)8(21)6(26-13)4-25-28(16,23)24/h5-6,8-9,13,21-22H,4H2,1-3H3,(H2,15,17,18)(H2,16,23,24)/t6-,8-,9-,13-/m1/s1	DRTHISUFMFDTKE-HTVVRFAVSA-N	475995	US10865208, Compound I-53::{(2R,3S,4R,5R)-5-[4-amino-3-(tert-butylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475995	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475995&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501240	442076062							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986907	Nc1ncnc2n(nc(SC3CCCC3O)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C15H22N6O7S2/c16-12-9-13(19-5-18-12)21(20-14(9)29-8-3-1-2-6(8)22)15-11(24)10(23)7(28-15)4-27-30(17,25)26/h5-8,10-11,15,22-24H,1-4H2,(H2,16,18,19)(H2,17,25,26)/t6?,7-,8?,10-,11-,15-/m1/s1	KAYQYQDTJTYBAY-MTNFPTKESA-N	475996	US10865208, Compound I-54::[(2R,3S,4R,5R)-5-(4-amino-3-{[(1R,2R)-2-hydroxycyclopentyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate and [(2R,3S,4R,5R)-5-(4-amino-3-{[(1S,2S)-2-hydroxycyclopentyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475996	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475996&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295465	442076063							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986908	CC(O)CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@H](O)[C@@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S2/c1-5(20)3-27-12-7-10(14)16-4-17-11(7)19(18-12)13-9(22)8(21)6(26-13)2-25-28(15,23)24/h4-6,8-9,13,20-22H,2-3H2,1H3,(H2,14,16,17)(H2,15,23,24)/t5?,6-,8+,9+,13-/m1/s1	DAYVSJUNMJCVNP-ZKNCWAAXSA-N	475997	US10865208, Compound I-55b::[(2R,3S,4R,5R)-5-(4-amino-3-{[(2R)-2-hydroxypropyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate or [(2R,3S,4R,5R)-5-(4-amino-3-{[(2S)-2-hydroxypropyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475997	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475997&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			156023128	442076064							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986909	CC(O)CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O7S2/c1-5(20)3-27-12-7-10(14)16-4-17-11(7)19(18-12)13-9(22)8(21)6(26-13)2-25-28(15,23)24/h4-6,8-9,13,20-22H,2-3H2,1H3,(H2,14,16,17)(H2,15,23,24)/t5?,6-,8-,9-,13-/m1/s1	DAYVSJUNMJCVNP-MNHQDWQPSA-N	475998	US10865208, Compound I-55a::[(2R,3S,4R,5R)-5-(4-amino-3-{[(2R)-2-hydroxypropyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate or [(2R,3S,4R,5R)-5-(4-amino-3-{[(2S)-2-hydroxypropyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475998	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475998&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500962	442076065							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986910	Nc1ncnc2n(nc(SC3CCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C14H20N6O6S2/c15-11-8-12(18-5-17-11)20(19-13(8)27-6-2-1-3-6)14-10(22)9(21)7(26-14)4-25-28(16,23)24/h5-7,9-10,14,21-22H,1-4H2,(H2,15,17,18)(H2,16,23,24)/t7-,9-,10-,14-/m1/s1	FHHIOVRQWOARQB-AKAIJSEGSA-N	475999	US10865208, Compound I-56::{(2R,3S,4R,5R)-5-[4-amino-3-(cyclobutylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=475999	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=475999&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500985	442076066							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986911	Nc1ncnc2n(nc(-c3ncco3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H15N7O7S/c14-10-6-7(12-16-1-2-25-12)19-20(11(6)18-4-17-10)13-9(22)8(21)5(27-13)3-26-28(15,23)24/h1-2,4-5,8-9,13,21-22H,3H2,(H2,14,17,18)(H2,15,23,24)/t5-,8-,9-,13-/m1/s1	NMPWZUOXVNWRGI-FITJORAGSA-N	476000	US10865208, Compound I-57::{(2R,3S,4R,5R)-5-[4-amino-3-(1,3-oxazol-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476000	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476000&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500338	442076067							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986912	CC(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O6S2/c1-5(2)26-12-7-10(14)16-4-17-11(7)19(18-12)13-9(21)8(20)6(25-13)3-24-27(15,22)23/h4-6,8-9,13,20-21H,3H2,1-2H3,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	CDIBRSZOZOHBQK-HTVVRFAVSA-N	476001	US10865208, Compound I-58::{(2R,3S,4R,5R)-5-[4-amino-3-(isopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476001	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476001&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500548	442076068							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986913	Nc1ncnc2n(nc(SCc3ccccn3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H19N7O6S2/c17-13-10-14(21-7-20-13)23(22-15(10)30-6-8-3-1-2-4-19-8)16-12(25)11(24)9(29-16)5-28-31(18,26)27/h1-4,7,9,11-12,16,24-25H,5-6H2,(H2,17,20,21)(H2,18,26,27)/t9-,11-,12-,16-/m1/s1	FRSDBONGUIWSIL-UBEDBUPSSA-N	476002	US10865208, Compound I-59::[(2R,3S,4R,5R)-5-{4-amino-3-[(pyridin-2-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476002	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476002&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			147556154	442076069							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986914	NC(=S)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H15N7O6S2/c12-8-4-5(9(13)25)17-18(10(4)16-2-15-8)11-7(20)6(19)3(24-11)1-23-26(14,21)22/h2-3,6-7,11,19-20H,1H2,(H2,13,25)(H2,12,15,16)(H2,14,21,22)/t3-,6-,7-,11-/m1/s1	OLHQWZZXQDNNEE-BBBNYMBOSA-N	476003	US10865208, Compound I-60::[(2R,3S,4R,5R)-5-(4-amino-3-carbamothioyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)- 3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476003	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476003&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151345158	442076070							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986915	Cn1cc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cn1	InChI=1S/C14H18N8O6S2/c1-21-3-6(2-19-21)29-13-8-11(15)17-5-18-12(8)22(20-13)14-10(24)9(23)7(28-14)4-27-30(16,25)26/h2-3,5,7,9-10,14,23-24H,4H2,1H3,(H2,15,17,18)(H2,16,25,26)/t7-,9-,10-,14-/m1/s1	LSVPBEMPGSDOFL-AKAIJSEGSA-N	476004	US10865208, Compound I-61::[(2R,3S,4R,5R)-5-{4-amino-3-[(1-methyl-1H-pyrazol-4-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476004	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476004&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500659	442076071							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986916	Nc1ncnc2n(nc(SC3CCCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C15H22N6O6S2/c16-12-9-13(19-6-18-12)21(20-14(9)28-7-3-1-2-4-7)15-11(23)10(22)8(27-15)5-26-29(17,24)25/h6-8,10-11,15,22-23H,1-5H2,(H2,16,18,19)(H2,17,24,25)/t8-,10-,11-,15-/m1/s1	QUFLBZCYGVEMNU-ORXWAGORSA-N	476005	US10865208, Compound I-62::{(2R,3S,4R,5R)-5-[4-amino-3-(cyclopentylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476005	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476005&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			149098788	442076072							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986917	Nc1ncnc2n(nc(SCc3ccc(F)cc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H19FN6O6S2/c18-9-3-1-8(2-4-9)6-31-16-11-14(19)21-7-22-15(11)24(23-16)17-13(26)12(25)10(30-17)5-29-32(20,27)28/h1-4,7,10,12-13,17,25-26H,5-6H2,(H2,19,21,22)(H2,20,27,28)/t10-,12-,13-,17-/m1/s1	IGVUAIALZXOROE-CNEMSGBDSA-N	476006	US10865208, Compound I-63::[(2R,3S,4R,5R)-5-{4-amino-3-[(4-fluorobenzyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476006	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476006&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295236	442076073							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986918	Nc1ncnc2n(nc(Sc3ccc(Cl)cc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H17ClN6O6S2/c17-7-1-3-8(4-2-7)30-15-10-13(18)20-6-21-14(10)23(22-15)16-12(25)11(24)9(29-16)5-28-31(19,26)27/h1-4,6,9,11-12,16,24-25H,5H2,(H2,18,20,21)(H2,19,26,27)/t9-,11-,12-,16-/m1/s1	MZMZXMMQQNHJOV-UBEDBUPSSA-N	476007	US10865208, Compound I-64::[(2R,3S,4R,5R)-5-{4-amino-3-[(4-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476007	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476007&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295242	442076074							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986919	Nc1ncnc2n(nc(SC3CC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H18N6O6S2/c14-10-7-11(17-4-16-10)19(18-12(7)26-5-1-2-5)13-9(21)8(20)6(25-13)3-24-27(15,22)23/h4-6,8-9,13,20-21H,1-3H2,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	ONUHFBYQASQOJY-HTVVRFAVSA-N	476008	US10865208, Compound I-65::{(2R,3S,4R,5R)-5-[4-amino-3-(cyclopropylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476008	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476008&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295233	442076075							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986920	Nc1ncnc2n(nc(Sc3ccncc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C15H17N7O6S2/c16-12-9-13(20-6-19-12)22(21-14(9)29-7-1-3-18-4-2-7)15-11(24)10(23)8(28-15)5-27-30(17,25)26/h1-4,6,8,10-11,15,23-24H,5H2,(H2,16,19,20)(H2,17,25,26)/t8-,10-,11-,15-/m1/s1	PCWHONGJJOQJCM-ORXWAGORSA-N	476009	US10865208, Compound I-66::{(2R,3S,4R,5R)-5-[4-amino-3-(pyridin-4-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476009	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476009&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148880022	442076076							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986921	Nc1ncnc2n(nc(SCc3cccc4ccccc34)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C21H22N6O6S2/c22-18-15-19(25-10-24-18)27(21-17(29)16(28)14(33-21)8-32-35(23,30)31)26-20(15)34-9-12-6-3-5-11-4-1-2-7-13(11)12/h1-7,10,14,16-17,21,28-29H,8-9H2,(H2,22,24,25)(H2,23,30,31)/t14-,16-,17-,21-/m1/s1	PYXNOIVWWYCRMP-VGKBRBPRSA-N	476010	US10865208, Compound I-67::[(2R,3S,4R,5R)-5-{4-amino-3-[(1-naphthylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476010	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476010&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148997153	442076077							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986922	Nc1ncnc2n(nc(-c3ccn[nH]3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O			476011	US10865208, Compound I-68::{(2R,3S,4R,5R)-5-[4-amino-3-(1H-pyrazol-5-yl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476011	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476011&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500312	442076078							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986923	Cc1cccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1	InChI=1S/C17H20N6O6S2/c1-8-3-2-4-9(5-8)30-16-11-14(18)20-7-21-15(11)23(22-16)17-13(25)12(24)10(29-17)6-28-31(19,26)27/h2-5,7,10,12-13,17,24-25H,6H2,1H3,(H2,18,20,21)(H2,19,26,27)/t10-,12-,13-,17-/m1/s1	YPIQMHCQPHVWIF-CNEMSGBDSA-N	476012	US10865208, Compound I-69::[(2R,3S,4R,5R)-5-{4-amino-3-[(3-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476012	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476012&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295256	442076079							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986924	CC(Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12)c1ccccc1	InChI=1S/C18H22N6O6S2/c1-9(10-5-3-2-4-6-10)31-17-12-15(19)21-8-22-16(12)24(23-17)18-14(26)13(25)11(30-18)7-29-32(20,27)28/h2-6,8-9,11,13-14,18,25-26H,7H2,1H3,(H2,19,21,22)(H2,20,27,28)/t9?,11-,13-,14-,18-/m1/s1	MERAJHAIEGWCIZ-MFHXWPCPSA-N	476013	US10865208, Compound I-70::[(2R,3S,4R,5R)-5-(4-amino-3-{[(1R)-1-phenylethyl]sulfanyl}-1H-pyrazolo[3,4- d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate and [(2R,3S,4R,5R)-5-(4-amino-3-{[(1S)-1-phenylethyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476013	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476013&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148469462	442076080							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986925	Nc1ncnc2n(nc(OCC=C)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H18N6O7S/c1-2-3-24-12-7-10(14)16-5-17-11(7)19(18-12)13-9(21)8(20)6(26-13)4-25-27(15,22)23/h2,5-6,8-9,13,20-21H,1,3-4H2,(H2,14,16,17)(H2,15,22,23)/t6-,8-,9-,13-/m1/s1	BDLNPDSSIHJJTH-HTVVRFAVSA-N	476014	US10865208, Compound I-71::{(2R,3S,4R,5R)-5-[3-(allyloxy)-4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3,4- dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476014	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476014&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500752	442076081							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986926	Nc1ncnc2n(nc(SC3CNC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C13H19N7O6S2/c14-10-7-11(18-4-17-10)20(19-12(7)27-5-1-16-2-5)13-9(22)8(21)6(26-13)3-25-28(15,23)24/h4-6,8-9,13,16,21-22H,1-3H2,(H2,14,17,18)(H2,15,23,24)/t6-,8-,9-,13-/m1/s1	GNWMELIPFNXQFA-HTVVRFAVSA-N	476015	US10865208, Compound I-72::{(2R,3S,4R,5R)-5-[4-amino-3-(azetidin-3-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476015	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476015&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501448	442076082							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986927	Nc1ncnc2n(nc(SCc3ccc(Cl)o3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C15H17ClN6O7S2/c16-8-2-1-6(28-8)4-30-14-9-12(17)19-5-20-13(9)22(21-14)15-11(24)10(23)7(29-15)3-27-31(18,25)26/h1-2,5,7,10-11,15,23-24H,3-4H2,(H2,17,19,20)(H2,18,25,26)/t7-,10-,11-,15-/m1/s1	WJAOGVGHJBDIKK-YPKZDWGUSA-N	476016	US10865208, Compound I-73::[(2R,3S,4R,5R)-5-(4-amino-3-{[(5-chloro-2-furyl)methyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476016	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476016&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500446	442076083							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986928	Cc1ccccc1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C17H20N6O6S2/c1-8-4-2-3-5-10(8)30-16-11-14(18)20-7-21-15(11)23(22-16)17-13(25)12(24)9(29-17)6-28-31(19,26)27/h2-5,7,9,12-13,17,24-25H,6H2,1H3,(H2,18,20,21)(H2,19,26,27)/t9-,12-,13-,17-/m1/s1	ZSFBVXWOBMEZGM-DMEFTLKTSA-N	476017	US10865208, Compound I-74::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476017	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476017&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500956	442076084							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986929	Nc1ncnc2n(nc(OCCCl)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H17ClN6O7S/c13-1-2-24-11-6-9(14)16-4-17-10(6)19(18-11)12-8(21)7(20)5(26-12)3-25-27(15,22)23/h4-5,7-8,12,20-21H,1-3H2,(H2,14,16,17)(H2,15,22,23)/t5-,7-,8-,12-/m1/s1	KYRMKADRLDQOTI-JTFADIMSSA-N	476018	US10865208, Compound I-75::{(2R,3S,4R,5R)-5-[4-amino-3-(2-chloroethoxy)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476018	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476018&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500957	442076085							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986930	Nc1ncnc2n(nc(OCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H20N6O7S/c18-14-11-15(21-8-20-14)23(22-16(11)28-6-9-4-2-1-3-5-9)17-13(25)12(24)10(30-17)7-29-31(19,26)27/h1-5,8,10,12-13,17,24-25H,6-7H2,(H2,18,20,21)(H2,19,26,27)/t10-,12-,13-,17-/m1/s1	IRZWOFPUKRWUFQ-CNEMSGBDSA-N	476019	US10865208, Compound I-76::{(2R,3S,4R,5R)-5-[4-amino-3-(benzyloxy)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476019	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476019&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500320	442076086							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986931	CC(C)CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C14H22N6O6S2/c1-6(2)4-27-13-8-11(15)17-5-18-12(8)20(19-13)14-10(22)9(21)7(26-14)3-25-28(16,23)24/h5-7,9-10,14,21-22H,3-4H2,1-2H3,(H2,15,17,18)(H2,16,23,24)/t7-,9-,10-,14-/m1/s1	BVJZFQUOFDHFEL-AKAIJSEGSA-N	476020	US10865208, Compound I-77::{(2R,3S,4R,5R)-5-[4-amino-3-(isobutylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476020	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476020&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501403	442076087							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986932	Nc1ncnc2n(nc(Sc3ccccc3Cl)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H17ClN6O6S2/c17-7-3-1-2-4-9(7)30-15-10-13(18)20-6-21-14(10)23(22-15)16-12(25)11(24)8(29-16)5-28-31(19,26)27/h1-4,6,8,11-12,16,24-25H,5H2,(H2,18,20,21)(H2,19,26,27)/t8-,11-,12-,16-/m1/s1	PKBYHTLNWSKTJB-LKGUXBDMSA-N	476021	US10865208, Compound I-78::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476021	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476021&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501434	442076088							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986933	Nc1ncnc2n(nc(I)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C10H13IN6O6S/c11-7-4-8(12)14-2-15-9(4)17(16-7)10-6(19)5(18)3(23-10)1-22-24(13,20)21/h2-3,5-6,10,18-19H,1H2,(H2,12,14,15)(H2,13,20,21)/t3-,5-,6-,10-/m1/s1	SCGBKODIOGUYPR-BHBWVORQSA-N	476022	US10865208, Compound I-79::[(2R,3S,4R,5R)-5-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4- dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476022	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476022&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500758	442076089							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986934	CN(C)CCSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C14H23N7O6S2/c1-20(2)3-4-28-13-8-11(15)17-6-18-12(8)21(19-13)14-10(23)9(22)7(27-14)5-26-29(16,24)25/h6-7,9-10,14,22-23H,3-5H2,1-2H3,(H2,15,17,18)(H2,16,24,25)/t7-,9-,10-,14-/m1/s1	JCTGBFAPKIJFCW-AKAIJSEGSA-N	476023	US10865208, Compound I-80::[(2R,3S,4R,5R)-5-(4-amino-3-{[2-(dimethylamino)ethyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476023	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476023&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500747	442076090							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986935	Cc1occc1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C15H18N6O7S2/c1-6-8(2-3-26-6)29-14-9-12(16)18-5-19-13(9)21(20-14)15-11(23)10(22)7(28-15)4-27-30(17,24)25/h2-3,5,7,10-11,15,22-23H,4H2,1H3,(H2,16,18,19)(H2,17,24,25)/t7-,10-,11-,15-/m1/s1	PITKDMXZDPNNKA-YPKZDWGUSA-N	476024	US10865208, Compound I-81::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-methyl-3-furyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476024	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476024&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500351	442076091							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986936	Nc1ncnc2n(nc(Sc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C16H18N6O6S2/c17-13-10-14(20-7-19-13)22(21-15(10)29-8-4-2-1-3-5-8)16-12(24)11(23)9(28-16)6-27-30(18,25)26/h1-5,7,9,11-12,16,23-24H,6H2,(H2,17,19,20)(H2,18,25,26)/t9-,11-,12-,16-/m1/s1	YHRJIUXBQBEGPM-UBEDBUPSSA-N	476025	US10865208, Compound I-82::{(2R,3S,4R,5R)-5-[4-amino-3-(phenylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476025	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476025&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500741	442076092							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986937	Nc1ncnc2n(nc(SCC(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H15F3N6O6S2/c13-12(14,15)2-28-10-5-8(16)18-3-19-9(5)21(20-10)11-7(23)6(22)4(27-11)1-26-29(17,24)25/h3-4,6-7,11,22-23H,1-2H2,(H2,16,18,19)(H2,17,24,25)/t4-,6-,7-,11-/m1/s1	LTGQVCPZURCPRS-RPKMEZRRSA-N	476026	US10865208, Compound I-83::[(2R,3S,4R,5R)-5-{4-amino-3-[(2,2,2-trifluoroethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476026	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476026&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295424	442076093							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986938	Nc1ncnc2n(nc(Sc3cccc4ccccc34)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C20H20N6O6S2/c21-17-14-18(24-9-23-17)26(20-16(28)15(27)12(32-20)8-31-34(22,29)30)25-19(14)33-13-7-3-5-10-4-1-2-6-11(10)13/h1-7,9,12,15-16,20,27-28H,8H2,(H2,21,23,24)(H2,22,29,30)/t12-,15-,16-,20-/m1/s1	LQOIEEMNQULFJZ-VXHCAWKWSA-N	476027	US10865208, Compound I-84::{(2R,3S,4R,5R)-5-[4-amino-3-(1-naphthylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476027	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476027&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500795	442076094							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986939	Nc1ncnc2n(nc(SC(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C11H14F2N6O6S2/c12-11(13)26-9-4-7(14)16-2-17-8(4)19(18-9)10-6(21)5(20)3(25-10)1-24-27(15,22)23/h2-3,5-6,10-11,20-21H,1H2,(H2,14,16,17)(H2,15,22,23)/t3-,5-,6-,10-/m1/s1	OIAOIFZYVKNUHS-BHBWVORQSA-N	476028	US10865208, Compound I-85::[(2R,3S,4R,5R)-5-{4-amino-3-[(difluoromethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476028	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476028&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148769034	442076095							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986940	Nc1ncnc2n(nc(SCC3(O)CCCCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H26N6O7S2/c18-13-10-14(21-8-20-13)23(22-15(10)31-7-17(26)4-2-1-3-5-17)16-12(25)11(24)9(30-16)6-29-32(19,27)28/h8-9,11-12,16,24-26H,1-7H2,(H2,18,20,21)(H2,19,27,28)/t9-,11-,12-,16-/m1/s1	IHSQLCQNVATDII-UBEDBUPSSA-N	476029	US10865208, Compound I-86::[(2R,3S,4R,5R)-5-(4-amino-3-{[(1-hydroxycyclohexyl)methyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476029	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476029&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500497	442076096							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986941	CS(=O)c1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H16N6O7S2/c1-25(20)10-5-8(12)14-3-15-9(5)17(16-10)11-7(19)6(18)4(24-11)2-23-26(13,21)22/h3-4,6-7,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,21,22)/t4-,6-,7-,11-,25?/m1/s1	RWCPYASVUIGMLN-XFSVYHPDSA-N	476030	US10865208, Compound I-87::{(2R,3S,4R,5R)-5-[4-amino-3-(methylsulfinyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476030	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476030&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501437	442076097							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986942	Nc1ncnc2n(nc(SCCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C18H22N6O6S2/c19-15-12-16(22-9-21-15)24(23-17(12)31-7-6-10-4-2-1-3-5-10)18-14(26)13(25)11(30-18)8-29-32(20,27)28/h1-5,9,11,13-14,18,25-26H,6-8H2,(H2,19,21,22)(H2,20,27,28)/t11-,13-,14-,18-/m1/s1	KQGPPZSMLKUHSW-XWXWGSFUSA-N	476031	US10865208, Compound I-88::[(2R,3S,4R,5R)-5-{4-amino-3-[(2-phenylethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476031	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476031&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295406	442076098							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986943	Cc1ccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1	InChI=1S/C17H20N6O6S2/c1-8-2-4-9(5-3-8)30-16-11-14(18)20-7-21-15(11)23(22-16)17-13(25)12(24)10(29-17)6-28-31(19,26)27/h2-5,7,10,12-13,17,24-25H,6H2,1H3,(H2,18,20,21)(H2,19,26,27)/t10-,12-,13-,17-/m1/s1	QJCZOZLJJUHSRJ-CNEMSGBDSA-N	476032	US10865208, Compound I-89::[(2R,3S,4R,5R)-5-{4-amino-3-[(4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476032	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476032&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295458	442076099							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986944	Nc1ncnc2n(nc(SCC#N)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C12H15N7O6S2/c13-1-2-26-11-6-9(14)16-4-17-10(6)19(18-11)12-8(21)7(20)5(25-12)3-24-27(15,22)23/h4-5,7-8,12,20-21H,2-3H2,(H2,14,16,17)(H2,15,22,23)/t5-,7-,8-,12-/m1/s1	OPSVFCQYPIERLA-JTFADIMSSA-N	476033	US10865208, Compound I-90::[(2R,3S,4R,5R)-5-{4-amino-3-[(cyanomethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476033	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476033&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295372	442076100							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986945	Nc1ncnc2n(nc(SCC3=CCCCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]1O	InChI=1S/C17H24N6O6S2/c18-14-11-15(21-8-20-14)23(22-16(11)30-7-9-4-2-1-3-5-9)17-13(25)12(24)10(29-17)6-28-31(19,26)27/h4,8,10,12-13,17,24-25H,1-3,5-7H2,(H2,18,20,21)(H2,19,26,27)/t10-,12-,13-,17-/m1/s1	WPCXPUTTXKYRBT-CNEMSGBDSA-N	476034	US10865208, Compound I-91::[(2R,3S,4R,5R)-5-{4-amino-3-[(cyclohex-1-en-1-ylmethyl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476034	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476034&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500640	442076101							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986946	CC1OCCC1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C15H22N6O7S2/c1-6-8(2-3-26-6)29-14-9-12(16)18-5-19-13(9)21(20-14)15-11(23)10(22)7(28-15)4-27-30(17,24)25/h5-8,10-11,15,22-23H,2-4H2,1H3,(H2,16,18,19)(H2,17,24,25)/t6?,7-,8?,10-,11-,15-/m1/s1	CLBWFPITVCIHLU-MTNFPTKESA-N	476035	US10865208, Compound I-92::[(2R,3S,4R,5R)-5-(4-amino-3-{[(2S,3R)-2-methyltetrahydrofuran-3-yl]sulfanyl}- 1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476035	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476035&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			147242690	442076102							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986947	CSCc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C12H18N6O6S2/c1-25-3-5-7-10(13)15-4-16-11(7)18(17-5)12-9(20)8(19)6(24-12)2-23-26(14,21)22/h4,6,8-9,12,19-20H,2-3H2,1H3,(H2,13,15,16)(H2,14,21,22)/t6-,8-,9-,12-/m1/s1	PCUHSZCTFUWPTA-WOUKDFQISA-N	476036	US10865208, Compound I-93::[(2R,3S,4R,5R)-5-{4-amino-3-[(methylsulfanyl)methyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3,4-dihydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476036	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476036&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500685	442076103							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986948	CSc1nn([C@@H]2O[C@@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C11H16N6O6S2/c1-24-10-5-8(12)14-3-15-9(5)17(16-10)11-7(19)6(18)4(23-11)2-22-25(13,20)21/h3-4,6-7,11,18-19H,2H2,1H3,(H2,12,14,15)(H2,13,20,21)/t4-,6+,7+,11+/m0/s1	KSULIUAOMXPISB-WWLWPKCJSA-N	476037	US10865208, Compound I-94::{(2S,3S,4R,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476037	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476037&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500907	442076104							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986949	CC(C)Sc1nn([C@@H]2O[C@@H](COS(N)(=O)=O)[C@@H](O)[C@H]2O)c2ncnc(N)c12	InChI=1S/C13H20N6O6S2/c1-5(2)26-12-7-10(14)16-4-17-11(7)19(18-12)13-9(21)8(20)6(25-13)3-24-27(15,22)23/h4-6,8-9,13,20-21H,3H2,1-2H3,(H2,14,16,17)(H2,15,22,23)/t6-,8+,9+,13+/m0/s1	CDIBRSZOZOHBQK-FCCZHNFCSA-N	476038	US10865208, Compound I-95::{(2S,3S,4R,5R)-5-[4-amino-3-(isopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3,4-dihydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476038	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476038&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500380	442076105							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986950	CSc1nn([C@@H]2O[C@@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C11H15FN6O5S2/c1-24-10-5-8(13)15-3-16-9(5)18(17-10)11-6(12)7(19)4(23-11)2-22-25(14,20)21/h3-4,6-7,11,19H,2H2,1H3,(H2,13,15,16)(H2,14,20,21)/t4-,6-,7+,11+/m0/s1	DBHGPHSNNKSOMZ-GWOKTTKASA-N	476039	US10865208, Compound I-96::{(2S,3R,4S,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476039	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476039&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500564	442076106							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986951	Nc1ncnc2n(nc(SCC3CC(F)(F)C3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H19F3N6O5S2/c16-9-10(25)7(3-28-31(20,26)27)29-14(9)24-12-8(11(19)21-5-22-12)13(23-24)30-4-6-1-15(17,18)2-6/h5-7,9-10,14,25H,1-4H2,(H2,19,21,22)(H2,20,26,27)/t7-,9+,10-,14-/m1/s1	JMXOAIRBWCSVFC-IEQSHNCZSA-N	476040	US10865208, Compound I-97::[(2R,3R,4S,5R)-5-(4-amino-3-{[(3,3-difluorocyclobutyl)methyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476040	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476040&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500750	442076107							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986952	Nc1ncnc2n(nc(SC(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C11H13F3N6O5S2/c12-5-6(21)3(1-24-27(16,22)23)25-10(5)20-8-4(7(15)17-2-18-8)9(19-20)26-11(13)14/h2-3,5-6,10-11,21H,1H2,(H2,15,17,18)(H2,16,22,23)/t3-,5+,6-,10-/m1/s1	TYPSOIIHMJUGPN-PLWWYIFASA-N	476041	US10865208, Compound I-98::[(2R,3R,4S,5R)-5-{4-amino-3-[(difluoromethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476041	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476041&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500803	442076108							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986953	Nc1ncnc2n(nc(OC(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C11H13F3N6O6S/c12-5-6(21)3(1-24-27(16,22)23)25-10(5)20-8-4(7(15)17-2-18-8)9(19-20)26-11(13)14/h2-3,5-6,10-11,21H,1H2,(H2,15,17,18)(H2,16,22,23)/t3-,5+,6-,10-/m1/s1	MMXDILQQJLNYAP-PLWWYIFASA-N	476042	US10865208, Compound I-99::{(2R,3R,4S,5R)-5-[4-amino-3-(difluoromethoxy)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476042	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476042&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500557	442076109							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986954	Cc1occc1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C15H17FN6O6S2/c1-6-8(2-3-26-6)29-14-9-12(17)19-5-20-13(9)22(21-14)15-10(16)11(23)7(28-15)4-27-30(18,24)25/h2-3,5,7,10-11,15,23H,4H2,1H3,(H2,17,19,20)(H2,18,24,25)/t7-,10+,11-,15-/m1/s1	RFNBKMMQDOOGSM-YRWRXJCHSA-N	476043	US10865208, Compound I-100::[(2R,3R,4S,5R)-5-{4-amino-3-[(2-methyl-3-furyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476043	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476043&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500822	442076110							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986955	CC(Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12)C(F)(F)F	InChI=1S/C13H16F4N6O5S2/c1-4(13(15,16)17)29-11-6-9(18)20-3-21-10(6)23(22-11)12-7(14)8(24)5(28-12)2-27-30(19,25)26/h3-5,7-8,12,24H,2H2,1H3,(H2,18,20,21)(H2,19,25,26)/t4?,5-,7+,8-,12-/m1/s1	BLJUYLMMTOXRGR-BVMHRXTHSA-N	476044	US10865208, Compound I-101::[(2R,3R,4S,5R)-5-(4-amino-3-{[(2R)-1,1,1-trifluoropropan-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476044	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476044&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500801	442076111							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986956	Cc1cccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)n1	InChI=1S/C16H18FN7O5S2/c1-7-3-2-4-9(22-7)30-15-10-13(18)20-6-21-14(10)24(23-15)16-11(17)12(25)8(29-16)5-28-31(19,26)27/h2-4,6,8,11-12,16,25H,5H2,1H3,(H2,18,20,21)(H2,19,26,27)/t8-,11+,12-,16-/m1/s1	HCWHGGXVSLNDJC-DGHXPGOUSA-N	476045	US10865208, Compound I-102::[(2R,3R,4S,5R)-5-{4-amino-3-[(6-methylpyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476045	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476045&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500461	442076112							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986957	Nc1ncnc2n(nc(SC3CCCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H21FN6O5S2/c16-10-11(23)8(5-26-29(18,24)25)27-15(10)22-13-9(12(17)19-6-20-13)14(21-22)28-7-3-1-2-4-7/h6-8,10-11,15,23H,1-5H2,(H2,17,19,20)(H2,18,24,25)/t8-,10+,11-,15-/m1/s1	OIZGHIGMCGBZEI-AFCLKFOHSA-N	476046	US10865208, Compound I-103::{(2R,3R,4S,5R)-5-[4-amino-3-(cyclopentylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476046	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476046&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500746	442076113							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986958	CCN(CC)CCSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C16H26FN7O5S2/c1-3-23(4-2)5-6-30-15-10-13(18)20-8-21-14(10)24(22-15)16-11(17)12(25)9(29-16)7-28-31(19,26)27/h8-9,11-12,16,25H,3-7H2,1-2H3,(H2,18,20,21)(H2,19,26,27)/t9-,11+,12-,16-/m1/s1	WPEGHVAHUPGESV-DFANHVJVSA-N	476047	US10865208, Compound I-104::[(2R,3R,4S,5R)-5-(4-amino-3-{[2-(diethylamino)ethyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476047	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476047&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152300092	442076114							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986959	COc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C11H15FN6O6S/c1-22-10-5-8(13)15-3-16-9(5)18(17-10)11-6(12)7(19)4(24-11)2-23-25(14,20)21/h3-4,6-7,11,19H,2H2,1H3,(H2,13,15,16)(H2,14,20,21)/t4-,6+,7-,11-/m1/s1	CJPZKCWNOSJROB-WAUSKZQCSA-N	476048	US10865208, Compound I-105::[(2R,3R,4S,5R)-5-(4-amino-3-methoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-4- fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476048	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476048&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500643	442076115							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986960	Nc1ncnc2n(nc(Sc3cccc(Cl)c3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16ClFN6O5S2/c17-7-2-1-3-8(4-7)30-15-10-13(19)21-6-22-14(10)24(23-15)16-11(18)12(25)9(29-16)5-28-31(20,26)27/h1-4,6,9,11-12,16,25H,5H2,(H2,19,21,22)(H2,20,26,27)/t9-,11+,12-,16-/m1/s1	XIZNXSSAZSFJJR-DFANHVJVSA-N	476049	US10865208, Compound I-106::[(2R,3R,4S,5R)-5-{4-amino-3-[(3-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476049	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476049&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500915	442076116							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986961	COc1cccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)n1	InChI=1S/C16H18FN7O6S2/c1-28-8-3-2-4-9(22-8)31-15-10-13(18)20-6-21-14(10)24(23-15)16-11(17)12(25)7(30-16)5-29-32(19,26)27/h2-4,6-7,11-12,16,25H,5H2,1H3,(H2,18,20,21)(H2,19,26,27)/t7-,11+,12-,16-/m1/s1	IYJXOKWJDXTNIK-NNNSJNRFSA-N	476050	US10865208, Compound I-107::[(2R,3R,4S,5R)-5-{4-amino-3-[(6-methoxypyridin-2-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476050	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476050&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295290	442076117							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986962	Nc1ncnc2n(nc(C3CC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C13H17FN6O5S/c14-8-10(21)6(3-24-26(16,22)23)25-13(8)20-12-7(11(15)17-4-18-12)9(19-20)5-1-2-5/h4-6,8,10,13,21H,1-3H2,(H2,15,17,18)(H2,16,22,23)/t6-,8+,10-,13-/m1/s1	MRZXZIMSNJPCIB-FIIPPMMWSA-N	476051	US10865208, Compound I-108::[(2R,3R,4S,5R)-5-(4-amino-3-cyclopropyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-4- fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476051	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476051&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500568	442076118							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986963	Nc1ncnc2n(nc(Sc3ccccc3F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16F2N6O5S2/c17-7-3-1-2-4-9(7)30-15-10-13(19)21-6-22-14(10)24(23-15)16-11(18)12(25)8(29-16)5-28-31(20,26)27/h1-4,6,8,11-12,16,25H,5H2,(H2,19,21,22)(H2,20,26,27)/t8-,11+,12-,16-/m1/s1	HEPRWHBSBVIGRV-DGHXPGOUSA-N	476052	US10865208, Compound I-109::[(2R,3R,4S,5R)-5-{4-amino-3-[(2-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476052	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476052&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295343	442076119							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986964	Cc1cc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)c(C)o1	InChI=1S/C16H19FN6O6S2/c1-6-3-9(7(2)28-6)30-15-10-13(18)20-5-21-14(10)23(22-15)16-11(17)12(24)8(29-16)4-27-31(19,25)26/h3,5,8,11-12,16,24H,4H2,1-2H3,(H2,18,20,21)(H2,19,25,26)/t8-,11+,12-,16-/m1/s1	GFNFTWNWXADORF-DGHXPGOUSA-N	476053	US10865208, Compound I-110::[(2R,3R,4S,5R)-5-{4-amino-3-[(2,5-dimethyl-3-furyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476053	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476053&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295225	442076120							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986965	Nc1ncnc2n(nc(Sc3ccc(cn3)[N+]([O-])=O)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H15FN8O7S2/c16-10-11(25)7(4-30-33(18,28)29)31-15(10)23-13-9(12(17)20-5-21-13)14(22-23)32-8-2-1-6(3-19-8)24(26)27/h1-3,5,7,10-11,15,25H,4H2,(H2,17,20,21)(H2,18,28,29)/t7-,10+,11-,15-/m1/s1	AJRJPPKWTNOSMI-YRWRXJCHSA-N	476054	US10865208, Compound I-111::[(2R,3R,4S,5R)-5-{4-amino-3-[(5-nitropyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476054	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476054&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295392	442076121							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986966	Cn1ccnc1CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C15H19FN8O5S2/c1-23-3-2-19-8(23)5-30-14-9-12(17)20-6-21-13(9)24(22-14)15-10(16)11(25)7(29-15)4-28-31(18,26)27/h2-3,6-7,10-11,15,25H,4-5H2,1H3,(H2,17,20,21)(H2,18,26,27)/t7-,10+,11-,15-/m1/s1	IVEAXBMPPRRSFH-YRWRXJCHSA-N	476055	US10865208, Compound I-112::[(2R,3R,4S,5R)-5-(4-amino-3-{[(1-methyl-1H-imidazol-2-yl)methyl]sulfanyl}- 1H-pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2- yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476055	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476055&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501313	442076122							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986967	Nc1ncnc2n(nc(Sc3ccccn3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H16FN7O5S2/c16-10-11(24)7(5-27-30(18,25)26)28-15(10)23-13-9(12(17)20-6-21-13)14(22-23)29-8-3-1-2-4-19-8/h1-4,6-7,10-11,15,24H,5H2,(H2,17,20,21)(H2,18,25,26)/t7-,10+,11-,15-/m1/s1	DSSBREMBRBSNND-YRWRXJCHSA-N	476056	US10865208, Compound I-113::{(2R,3R,4S,5R)-5-[4-amino-3-(pyridin-2-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476056	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476056&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295429	442076123							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986968	Cc1ccnc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)c1	InChI=1S/C16H18FN7O5S2/c1-7-2-3-20-9(4-7)30-15-10-13(18)21-6-22-14(10)24(23-15)16-11(17)12(25)8(29-16)5-28-31(19,26)27/h2-4,6,8,11-12,16,25H,5H2,1H3,(H2,18,21,22)(H2,19,26,27)/t8-,11+,12-,16-/m1/s1	XORHVEPGHBFPLP-DGHXPGOUSA-N	476057	US10865208, Compound I-114::[(2R,3R,4S,5R)-5-{4-amino-3-[(4-methylpyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476057	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476057&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295371	442076124							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986969	CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C11H15FN6O5S2/c1-24-10-5-8(13)15-3-16-9(5)18(17-10)11-6(12)7(19)4(23-11)2-22-25(14,20)21/h3-4,6-7,11,19H,2H2,1H3,(H2,13,15,16)(H2,14,20,21)/t4-,6+,7-,11-/m1/s1	DBHGPHSNNKSOMZ-WAUSKZQCSA-N	476058	US10865208, Compound I-115::{(2R,3R,4S,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476058	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476058&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501393	442076125							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986970	Nc1ncnc2n(nc(Sc3cccc(F)c3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16F2N6O5S2/c17-7-2-1-3-8(4-7)30-15-10-13(19)21-6-22-14(10)24(23-15)16-11(18)12(25)9(29-16)5-28-31(20,26)27/h1-4,6,9,11-12,16,25H,5H2,(H2,19,21,22)(H2,20,26,27)/t9-,11+,12-,16-/m1/s1	OTIUXZZVMBQXEK-DFANHVJVSA-N	476059	US10865208, Compound I-116::[(2R,3R,4S,5R)-5-{4-amino-3-[(3-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476059	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476059&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295223	442076126							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986971	Nc1ncnc2n(nc(Sc3cc(ccn3)C(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H15F4N7O5S2/c17-10-11(28)7(4-31-34(22,29)30)32-15(10)27-13-9(12(21)24-5-25-13)14(26-27)33-8-3-6(1-2-23-8)16(18,19)20/h1-3,5,7,10-11,15,28H,4H2,(H2,21,24,25)(H2,22,29,30)/t7-,10+,11-,15-/m1/s1	DSPYCJYEUFPWIN-YRWRXJCHSA-N	476060	US10865208, Compound I-117::[(2R,3R,4S,5R)-5-(4-amino-3-{[4-(trifluoromethyl)pyridin-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476060	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476060&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			150087951	442076127							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986972	CC(C)(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C14H21FN6O5S2/c1-14(2,3)27-12-7-10(16)18-5-19-11(7)21(20-12)13-8(15)9(22)6(26-13)4-25-28(17,23)24/h5-6,8-9,13,22H,4H2,1-3H3,(H2,16,18,19)(H2,17,23,24)/t6-,8+,9-,13-/m1/s1	QXESRVIOJICIGF-GURMABIDSA-N	476061	US10865208, Compound I-118::{(2R,3R,4S,5R)-5-[4-amino-3-(tert-butylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476061	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476061&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500496	442076128							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986973	Nc1ncnc2n(nc(SCc3ccccn3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H18FN7O5S2/c17-11-12(25)9(5-28-31(19,26)27)29-16(11)24-14-10(13(18)21-7-22-14)15(23-24)30-6-8-3-1-2-4-20-8/h1-4,7,9,11-12,16,25H,5-6H2,(H2,18,21,22)(H2,19,26,27)/t9-,11+,12-,16-/m1/s1	PJHNRJBKJDCYJO-DFANHVJVSA-N	476062	US10865208, Compound I-119::[(2R,3R,4S,5R)-5-{4-amino-3-[(pyridin-2-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476062	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476062&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148914634	442076129							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986974	CCC(CC)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C15H23FN6O5S2/c1-3-7(4-2)28-14-9-12(17)19-6-20-13(9)22(21-14)15-10(16)11(23)8(27-15)5-26-29(18,24)25/h6-8,10-11,15,23H,3-5H2,1-2H3,(H2,17,19,20)(H2,18,24,25)/t8-,10+,11-,15-/m1/s1	SRVORHXYXKBAFU-AFCLKFOHSA-N	476063	US10865208, Compound I-120::{(2R,3R,4S,5R)-5-[4-amino-3-(pentan-3-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476063	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476063&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500770	442076130							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986975	Nc1ncnc2n(nc(SCc3cccnc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H18FN7O5S2/c17-11-12(25)9(5-28-31(19,26)27)29-16(11)24-14-10(13(18)21-7-22-14)15(23-24)30-6-8-2-1-3-20-4-8/h1-4,7,9,11-12,16,25H,5-6H2,(H2,18,21,22)(H2,19,26,27)/t9-,11+,12-,16-/m1/s1	MOKNSIVUSSVAST-DFANHVJVSA-N	476064	US10865208, Compound I-121::[(2R,3R,4S,5R)-5-{4-amino-3-[(pyridin-3-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476064	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476064&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151102506	442076131							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986976	Nc1ncnc2n(nc(SC3CCCCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H23FN6O5S2/c17-11-12(24)9(6-27-30(19,25)26)28-16(11)23-14-10(13(18)20-7-21-14)15(22-23)29-8-4-2-1-3-5-8/h7-9,11-12,16,24H,1-6H2,(H2,18,20,21)(H2,19,25,26)/t9-,11+,12-,16-/m1/s1	ZQWJBMKPPPIQMZ-DFANHVJVSA-N	476065	US10865208, Compound I-122::{(2R,3R,4S,5R)-5-[4-amino-3-(cyclohexylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476065	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476065&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500749	442076132							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986977	Nc1ncnc2n(nc(SC3CCOC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C14H19FN6O6S2/c15-9-10(22)7(4-26-29(17,23)24)27-14(9)21-12-8(11(16)18-5-19-12)13(20-21)28-6-1-2-25-3-6/h5-7,9-10,14,22H,1-4H2,(H2,16,18,19)(H2,17,23,24)/t6?,7-,9+,10-,14-/m1/s1	MIWYWWSVSOGPQQ-OEJSBOTNSA-N	476066	US10865208, Compound I-123::[(2R,3R,4S,5R)-5-{4-amino-3-[(3R)-tetrahydrofuran-3-ylsulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476066	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476066&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295305	442076133							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986978	Nc1ncnc2n(nc(SCc3ccncc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H18FN7O5S2/c17-11-12(25)9(5-28-31(19,26)27)29-16(11)24-14-10(13(18)21-7-22-14)15(23-24)30-6-8-1-3-20-4-2-8/h1-4,7,9,11-12,16,25H,5-6H2,(H2,18,21,22)(H2,19,26,27)/t9-,11+,12-,16-/m1/s1	PKPGEAHNFPEFKX-DFANHVJVSA-N	476067	US10865208, Compound I-124::[(2R,3R,4S,5R)-5-{4-amino-3-[(pyridin-4-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476067	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476067&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148923808	442076134							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986979	Cn1ccnc1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C14H17FN8O5S2/c1-22-3-2-18-14(22)29-12-7-10(16)19-5-20-11(7)23(21-12)13-8(15)9(24)6(28-13)4-27-30(17,25)26/h2-3,5-6,8-9,13,24H,4H2,1H3,(H2,16,19,20)(H2,17,25,26)/t6-,8+,9-,13-/m1/s1	AKMOSENHNVKRKU-GURMABIDSA-N	476068	US10865208, Compound I-125::[(2R,3R,4S,5R)-5-{4-amino-3-[(1-methyl-1H-imidazol-2-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476068	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476068&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501282	442076135							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986980	Nc1ncnc2n(nc(Sc3ccc(F)cc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16F2N6O5S2/c17-7-1-3-8(4-2-7)30-15-10-13(19)21-6-22-14(10)24(23-15)16-11(18)12(25)9(29-16)5-28-31(20,26)27/h1-4,6,9,11-12,16,25H,5H2,(H2,19,21,22)(H2,20,26,27)/t9-,11+,12-,16-/m1/s1	ADFFYGCSSCXBDJ-DFANHVJVSA-N	476069	US10865208, Compound I-126::[(2R,3R,4S,5R)-5-{4-amino-3-[(4-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476069	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476069&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			149621466	442076136							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986981	Nc1ncnc2n(nc(SCc3cccnn3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H17FN8O5S2/c16-10-11(25)8(4-28-31(18,26)27)29-15(10)24-13-9(12(17)19-6-20-13)14(23-24)30-5-7-2-1-3-21-22-7/h1-3,6,8,10-11,15,25H,4-5H2,(H2,17,19,20)(H2,18,26,27)/t8-,10+,11-,15-/m1/s1	KJJMYUKNTQNTBJ-AFCLKFOHSA-N	476070	US10865208, Compound I-127::[(2R,3R,4S,5R)-5-{4-amino-3-[(pyridazin-3-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476070	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476070&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			150818342	442076137							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986982	Nc1ncnc2n(nc(SCc3ccnnc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H17FN8O5S2/c16-10-11(25)8(4-28-31(18,26)27)29-15(10)24-13-9(12(17)19-6-20-13)14(23-24)30-5-7-1-2-21-22-3-7/h1-3,6,8,10-11,15,25H,4-5H2,(H2,17,19,20)(H2,18,26,27)/t8-,10+,11-,15-/m1/s1	VJULSRNDKGJSPC-AFCLKFOHSA-N	476071	US10865208, Compound I-128::[(2R,3R,4S,5R)-5-{4-amino-3-[(pyridazin-4-ylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476071	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476071&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152143969	442076138							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986983	CC(C)C(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C15H23FN6O5S2/c1-6(2)7(3)28-14-9-12(17)19-5-20-13(9)22(21-14)15-10(16)11(23)8(27-15)4-26-29(18,24)25/h5-8,10-11,15,23H,4H2,1-3H3,(H2,17,19,20)(H2,18,24,25)/t7?,8-,10+,11-,15-/m1/s1	BBPAZQCPQCGORX-XAZCMVNQSA-N	476072	US10865208, Compound I-129::[(2R,3R,4S,5R)-5-(4-amino-3-{[(2R)-3-methylbutan-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476072	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476072&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501397	442076139							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986984	Nc1ncnc2n(nc(Sc3cc(ccn3)C#N)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H15FN8O5S2/c17-11-12(26)8(5-29-32(20,27)28)30-16(11)25-14-10(13(19)22-6-23-14)15(24-25)31-9-3-7(4-18)1-2-21-9/h1-3,6,8,11-12,16,26H,5H2,(H2,19,22,23)(H2,20,27,28)/t8-,11+,12-,16-/m1/s1	OWGKKVLZIBVLKH-DGHXPGOUSA-N	476073	US10865208, Compound I-130::[(2R,3R,4S,5R)-5-{4-amino-3-[(4-cyanopyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476073	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476073&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501247	442076140							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986985	Nc1ncnc2n(nc(SCC3CC3(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C14H17F3N6O5S2/c15-8-9(24)6(2-27-30(19,25)26)28-13(8)23-11-7(10(18)20-4-21-11)12(22-23)29-3-5-1-14(5,16)17/h4-6,8-9,13,24H,1-3H2,(H2,18,20,21)(H2,19,25,26)/t5?,6-,8+,9-,13-/m1/s1	ATXGUCPEUZDXGD-RNCGBASLSA-N	476074	US10865208, Compound I-131::{(2R,3R,4S,5R)-5-[4-amino-3-({[(1R)-2,2-difluorocyclopropyl]methyl}sulfanyl)- 1H-pyrazolo[3,4-d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2- yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476074	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476074&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			147011263	442076141							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986986	Nc1ncnc2n(nc(Sc3ccc(cc3)C(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C17H16F4N6O5S2/c18-11-12(28)9(5-31-34(23,29)30)32-16(11)27-14-10(13(22)24-6-25-14)15(26-27)33-8-3-1-7(2-4-8)17(19,20)21/h1-4,6,9,11-12,16,28H,5H2,(H2,22,24,25)(H2,23,29,30)/t9-,11+,12-,16-/m1/s1	CQUGUZUKBASPEE-DFANHVJVSA-N	476075	US10865208, Compound I-132::[(2R,3R,4S,5R)-5-(4-amino-3-{[4-(trifluoromethyl)phenyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476075	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476075&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500759	442076142							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986987	Nc1ncnc2n(nc(Sc3ccc(Cl)cc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16ClFN6O5S2/c17-7-1-3-8(4-2-7)30-15-10-13(19)21-6-22-14(10)24(23-15)16-11(18)12(25)9(29-16)5-28-31(20,26)27/h1-4,6,9,11-12,16,25H,5H2,(H2,19,21,22)(H2,20,26,27)/t9-,11+,12-,16-/m1/s1	WQNRDZMHYWITDB-DFANHVJVSA-N	476076	US10865208, Compound I-133::[(2R,3R,4S,5R)-5-{4-amino-3-[(4-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476076	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476076&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501188	442076143							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986988	Cn1cncc1Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C14H17FN8O5S2/c1-22-5-18-2-7(22)29-13-8-11(16)19-4-20-12(8)23(21-13)14-9(15)10(24)6(28-14)3-27-30(17,25)26/h2,4-6,9-10,14,24H,3H2,1H3,(H2,16,19,20)(H2,17,25,26)/t6-,9+,10-,14-/m1/s1	KCJOJEZZFTUODC-ZODIEJGPSA-N	476077	US10865208, Compound I-134::[(2R,3R,4S,5R)-5-{4-amino-3-[(1-methyl-1H-imidazol-5-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476077	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476077&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500639	442076144							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986989	Nc1ncnc2n(nc(SCC3CC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C14H19FN6O5S2/c15-9-10(22)7(3-25-28(17,23)24)26-14(9)21-12-8(11(16)18-5-19-12)13(20-21)27-4-6-1-2-6/h5-7,9-10,14,22H,1-4H2,(H2,16,18,19)(H2,17,23,24)/t7-,9+,10-,14-/m1/s1	YWJANQKPRBAAER-IEQSHNCZSA-N	476078	US10865208, Compound I-135::[(2R,3R,4S,5R)-5-{4-amino-3-[(cyclopropylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476078	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476078&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501497	442076145							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986990	CCC(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C14H21FN6O5S2/c1-3-6(2)27-13-8-11(16)18-5-19-12(8)21(20-13)14-9(15)10(22)7(26-14)4-25-28(17,23)24/h5-7,9-10,14,22H,3-4H2,1-2H3,(H2,16,18,19)(H2,17,23,24)/t6?,7-,9+,10-,14-/m1/s1	KVTPEDLFINNQQC-OEJSBOTNSA-N	476079	US10865208, Compound I-136::US10865208, Compound I-136b::[(2R,3R,4S,5R)-5-{4-amino-3-[(2R)-butan-2-ylsulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476079&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500601	442076146							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986991	CCC(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C14H21FN6O5S2/c1-3-6(2)27-13-8-11(16)18-5-19-12(8)21(20-13)14-9(15)10(22)7(26-14)4-25-28(17,23)24/h5-7,9-10,14,22H,3-4H2,1-2H3,(H2,16,18,19)(H2,17,23,24)/t6?,7-,9+,10-,14-/m1/s1	KVTPEDLFINNQQC-OEJSBOTNSA-N	476079	US10865208, Compound I-136::US10865208, Compound I-136b::[(2R,3R,4S,5R)-5-{4-amino-3-[(2R)-butan-2-ylsulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476079	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476079&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500601	442076146							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986992	CCC(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@H](O)[C@H]2F)c2ncnc(N)c12	InChI=1S/C14H21FN6O5S2/c1-3-6(2)27-13-8-11(16)18-5-19-12(8)21(20-13)14-9(15)10(22)7(26-14)4-25-28(17,23)24/h5-7,9-10,14,22H,3-4H2,1-2H3,(H2,16,18,19)(H2,17,23,24)/t6?,7-,9-,10+,14-/m1/s1	KVTPEDLFINNQQC-QWWOWGKNSA-N	476081	US10865208, Compound I-136a::[(2R,3R,4S,5R)-5-{4-amino-3-[(2R)-butan-2-ylsulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate or [(2R,3R,4S,5R)-5-{4-amino-3-[(2S)-butan-2-ylsulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476081	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476081&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			156023129	442076147							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986993	Cn1cnc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)c1	InChI=1S/C14H17FN8O5S2/c1-22-2-7(20-5-22)29-13-8-11(16)18-4-19-12(8)23(21-13)14-9(15)10(24)6(28-14)3-27-30(17,25)26/h2,4-6,9-10,14,24H,3H2,1H3,(H2,16,18,19)(H2,17,25,26)/t6-,9+,10-,14-/m1/s1	BXFCYQULLLLSKF-ZODIEJGPSA-N	476082	US10865208, Compound I-137::[(2R,3R,4S,5R)-5-{4-amino-3-[(1-methyl-1H-imidazol-4-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476082	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476082&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500666	442076148							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986994	Nc1ncnc2n(nc(Sc3cccnc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H16FN7O5S2/c16-10-11(24)8(5-27-30(18,25)26)28-15(10)23-13-9(12(17)20-6-21-13)14(22-23)29-7-2-1-3-19-4-7/h1-4,6,8,10-11,15,24H,5H2,(H2,17,20,21)(H2,18,25,26)/t8-,10+,11-,15-/m1/s1	JYXZRDAMABOIOT-AFCLKFOHSA-N	476083	US10865208, Compound I-138::{(2R,3R,4S,5R)-5-[4-amino-3-(pyridin-3-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476083	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476083&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500910	442076149							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986995	CC(C)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C13H19FN6O5S2/c1-5(2)26-12-7-10(15)17-4-18-11(7)20(19-12)13-8(14)9(21)6(25-13)3-24-27(16,22)23/h4-6,8-9,13,21H,3H2,1-2H3,(H2,15,17,18)(H2,16,22,23)/t6-,8+,9-,13-/m1/s1	GXZMWGQFGQGFLM-GURMABIDSA-N	476084	US10865208, Compound I-139::{(2R,3R,4S,5R)-5-[4-amino-3-(isopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476084	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476084&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500340	442076150							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986996	CC1CC1CSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C15H21FN6O5S2/c1-6-2-7(6)4-28-14-9-12(17)19-5-20-13(9)22(21-14)15-10(16)11(23)8(27-15)3-26-29(18,24)25/h5-8,10-11,15,23H,2-4H2,1H3,(H2,17,19,20)(H2,18,24,25)/t6?,7?,8-,10+,11-,15-/m1/s1	RUUVWRCQGIZHDL-YMRXHTBVSA-N	476085	US10865208, Compound I-140::{(2R,3R,4S,5R)-5-[4-amino-3-({[(1R,2R)-2-methylcyclopropyl]methyl}sulfanyl)- 1H-pyrazolo[3,4-d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2- yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476085	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476085&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295263	442076151							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986997	Cc1cccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)c1	InChI=1S/C17H19FN6O5S2/c1-8-3-2-4-9(5-8)30-16-11-14(19)21-7-22-15(11)24(23-16)17-12(18)13(25)10(29-17)6-28-31(20,26)27/h2-5,7,10,12-13,17,25H,6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,12+,13-,17-/m1/s1	NUCKXYNLHCNDCE-HWAANXBSSA-N	476086	US10865208, Compound I-141::[(2R,3R,4S,5R)-5-{4-amino-3-[(3-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476086	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476086&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295308	442076152							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986998	Nc1ncnc2n(nc(SC(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C11H12F4N6O5S2/c12-5-6(22)3(1-25-28(17,23)24)26-10(5)21-8-4(7(16)18-2-19-8)9(20-21)27-11(13,14)15/h2-3,5-6,10,22H,1H2,(H2,16,18,19)(H2,17,23,24)/t3-,5+,6-,10-/m1/s1	BGINPWPNJJRYOQ-PLWWYIFASA-N	476087	US10865208, Compound I-142::[(2R,3R,4S,5R)-5-{4-amino-3-[(trifluoromethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476087	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476087&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			149766594	442076153							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
986999	Nc1ncnc2n(nc(Sc3ccc(cn3)C(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H15F4N7O5S2/c17-10-11(28)7(4-31-34(22,29)30)32-15(10)27-13-9(12(21)24-5-25-13)14(26-27)33-8-2-1-6(3-23-8)16(18,19)20/h1-3,5,7,10-11,15,28H,4H2,(H2,21,24,25)(H2,22,29,30)/t7-,10+,11-,15-/m1/s1	GTBSHHQIVPSXPL-YRWRXJCHSA-N	476088	US10865208, Compound I-143::[(2R,3R,4S,5R)-5-(4-amino-3-{[5-(trifluoromethyl)pyridin-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476088	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476088&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			150347763	442076154							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987000	CC(CO)Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C13H19FN6O6S2/c1-5(2-21)27-12-7-10(15)17-4-18-11(7)20(19-12)13-8(14)9(22)6(26-13)3-25-28(16,23)24/h4-6,8-9,13,21-22H,2-3H2,1H3,(H2,15,17,18)(H2,16,23,24)/t5?,6-,8+,9-,13-/m1/s1	OTIMURPVRWVZKU-RNCGBASLSA-N	476089	US10865208, Compound I-144::[(2R,3R,4S,5R)-5-(4-amino-3-{[(2R)-1-hydroxypropan-2-yl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476089	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476089&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500978	442076155							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987001	Cn1cc(CSc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)cn1	InChI=1S/C15H19FN8O5S2/c1-23-3-7(2-21-23)5-30-14-9-12(17)19-6-20-13(9)24(22-14)15-10(16)11(25)8(29-15)4-28-31(18,26)27/h2-3,6,8,10-11,15,25H,4-5H2,1H3,(H2,17,19,20)(H2,18,26,27)/t8-,10+,11-,15-/m1/s1	VIQHOJUCGMVEGI-AFCLKFOHSA-N	476090	US10865208, Compound I-145::[(2R,3R,4S,5R)-5-(4-amino-3-{[(1-methyl-1H-pyrazol-4-yl)methyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476090	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476090&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500562	442076156							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987002	Nc1ncnc2n(nc(Sc3ccc(Cl)cn3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H15ClFN7O5S2/c16-6-1-2-8(20-3-6)30-14-9-12(18)21-5-22-13(9)24(23-14)15-10(17)11(25)7(29-15)4-28-31(19,26)27/h1-3,5,7,10-11,15,25H,4H2,(H2,18,21,22)(H2,19,26,27)/t7-,10+,11-,15-/m1/s1	GYRNINPQHAOGRL-YRWRXJCHSA-N	476091	US10865208, Compound I-146::[(2R,3R,4S,5R)-5-{4-amino-3-[(5-chloropyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476091	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476091&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500718	442076157							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987003	Nc1ncnc2n(nc(SC3CCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C14H19FN6O5S2/c15-9-10(22)7(4-25-28(17,23)24)26-14(9)21-12-8(11(16)18-5-19-12)13(20-21)27-6-2-1-3-6/h5-7,9-10,14,22H,1-4H2,(H2,16,18,19)(H2,17,23,24)/t7-,9+,10-,14-/m1/s1	KWSHSNZMBLZIQV-IEQSHNCZSA-N	476092	US10865208, Compound I-147::{(2R,3R,4S,5R)-5-[4-amino-3-(cyclobutylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476092	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476092&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500405	442076158							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987004	Nc1ncnc2n(nc(SCC3CCC3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H21FN6O5S2/c16-10-11(23)8(4-26-29(18,24)25)27-15(10)22-13-9(12(17)19-6-20-13)14(21-22)28-5-7-2-1-3-7/h6-8,10-11,15,23H,1-5H2,(H2,17,19,20)(H2,18,24,25)/t8-,10+,11-,15-/m1/s1	UTCUPJWOPPSLET-AFCLKFOHSA-N	476093	US10865208, Compound I-148::[(2R,3R,4S,5R)-5-{4-amino-3-[(cyclobutylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476093	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476093&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152062997	442076159							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987005	CC(Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12)C#N	InChI=1S/C13H16FN7O5S2/c1-5(2-15)27-12-7-10(16)18-4-19-11(7)21(20-12)13-8(14)9(22)6(26-13)3-25-28(17,23)24/h4-6,8-9,13,22H,3H2,1H3,(H2,16,18,19)(H2,17,23,24)/t5?,6-,8+,9-,13-/m1/s1	RGCXRAKMKIPSQI-RNCGBASLSA-N	476094	US10865208, Compound I-149::[(2R,3R,4S,5R)-5-(4-amino-3-{[(1R)-1-cyanoethyl]sulfanyl}-1H-pyrazolo[3,4- d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476094	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476094&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500549	442076160							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987006	Nc1ncnc2n(nc(Sc3ccncc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C15H16FN7O5S2/c16-10-11(24)8(5-27-30(18,25)26)28-15(10)23-13-9(12(17)20-6-21-13)14(22-23)29-7-1-3-19-4-2-7/h1-4,6,8,10-11,15,24H,5H2,(H2,17,20,21)(H2,18,25,26)/t8-,10+,11-,15-/m1/s1	WEQFQKJBGVAWHO-AFCLKFOHSA-N	476095	US10865208, Compound I-150::{(2R,3R,4S,5R)-5-[4-amino-3-(pyridin-4-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476095	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476095&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500705	442076161							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987007	Nc1ncnc2n(nc(SCCO)c12)[C@@H]1O[C@H](CNS(O)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C12H17FN6O6S2/c13-7-8(21)5(3-17-27(22,23)24)25-12(7)19-10-6(9(14)15-4-16-10)11(18-19)26-2-1-20/h4-5,7-8,12,17,20-21H,1-3H2,(H2,14,15,16)(H,22,23,24)/t5-,7+,8-,12-/m1/s1	JTUOXHCPUNUFHI-ADVRJHOBSA-N	476096	US10865208, Compound I-151::[(2R,3R,4S,5R)-5-{4-amino-3-[(2-hydroxyethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476096	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476096&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295354	442076162					C01614		1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987008	Cc1ccc(Sc2nn([C@@H]3O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]3F)c3ncnc(N)c23)nc1	InChI=1S/C16H18FN7O5S2/c1-7-2-3-9(20-4-7)30-15-10-13(18)21-6-22-14(10)24(23-15)16-11(17)12(25)8(29-16)5-28-31(19,26)27/h2-4,6,8,11-12,16,25H,5H2,1H3,(H2,18,21,22)(H2,19,26,27)/t8-,11+,12-,16-/m1/s1	YNACTGBGVODYGI-DGHXPGOUSA-N	476097	US10865208, Compound I-152::[(2R,3R,4S,5R)-5-{4-amino-3-[(5-methylpyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		<20							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476097	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476097&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152548667	442076163							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987009	Nc1ncnc2n(nc(Sc3cccc(c3)C#N)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C17H16FN7O5S2/c18-12-13(26)10(6-29-32(21,27)28)30-17(12)25-15-11(14(20)22-7-23-15)16(24-25)31-9-3-1-2-8(4-9)5-19/h1-4,7,10,12-13,17,26H,6H2,(H2,20,22,23)(H2,21,27,28)/t10-,12+,13-,17-/m1/s1	WODGLTBPVGPLJK-HWAANXBSSA-N	476098	US10865208, Compound I-153::[(2R,3R,4S,5R)-5-{4-amino-3-[(3-cyanophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476098	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476098&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152294955	442076164							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987010	COCCSc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12	InChI=1S/C13H19FN6O6S2/c1-24-2-3-27-12-7-10(15)17-5-18-11(7)20(19-12)13-8(14)9(21)6(26-13)4-25-28(16,22)23/h5-6,8-9,13,21H,2-4H2,1H3,(H2,15,17,18)(H2,16,22,23)/t6-,8+,9-,13-/m1/s1	JFDGFAPWZQVDQV-GURMABIDSA-N	476099	US10865208, Compound I-154::[(2R,3R,4S,5R)-5-{4-amino-3-[(2-methoxyethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476099	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476099&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295307	442076165							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987011	Nc1ncnc2n(nc(SCc3ccccc3)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C17H19FN6O5S2/c18-12-13(25)10(6-28-31(20,26)27)29-17(12)24-15-11(14(19)21-8-22-15)16(23-24)30-7-9-4-2-1-3-5-9/h1-5,8,10,12-13,17,25H,6-7H2,(H2,19,21,22)(H2,20,26,27)/t10-,12+,13-,17-/m1/s1	ZBOUXGUUVJJFRF-HWAANXBSSA-N	476100	US10865208, Compound I-155::{(2R,3R,4S,5R)-5-[4-amino-3-(benzylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476100	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476100&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295246	442076166							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987012	Nc1ncnc2n(nc(Sc3nnc4ccccn34)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C16H16FN9O5S2/c17-10-11(27)7(5-30-33(19,28)29)31-15(10)26-13-9(12(18)20-6-21-13)14(24-26)32-16-23-22-8-3-1-2-4-25(8)16/h1-4,6-7,10-11,15,27H,5H2,(H2,18,20,21)(H2,19,28,29)/t7-,10+,11-,15-/m1/s1	SKAPFPJAQNLYLE-YRWRXJCHSA-N	476101	US10865208, Compound I-156::{(2R,3R,4S,5R)-5-[4-amino-3-([1,2,4]triazolo[4,3-a]pyridin-3-ylsulfanyl)-1H- pyrazolo[3,4-d]pyrimidin-1-yl]-4-fluoro-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476101	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476101&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500637	442076167							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987013	CC(Sc1nn([C@@H]2O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]2F)c2ncnc(N)c12)C1CC1	InChI=1S/C15H21FN6O5S2/c1-6(7-2-3-7)28-14-9-12(17)19-5-20-13(9)22(21-14)15-10(16)11(23)8(27-15)4-26-29(18,24)25/h5-8,10-11,15,23H,2-4H2,1H3,(H2,17,19,20)(H2,18,24,25)/t6?,8-,10+,11-,15-/m1/s1	UCAADRNQVSQFOL-KDFWFHNXSA-N	476102	US10865208, Compound I-157::[(2R,3R,4S,5R)-5-(4-amino-3-{[(1R)-1-cyclopropylethyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476102	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476102&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501443	442076168							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987014	Nc1ncnc2n(nc(Sc3cccc(c3)C(F)(F)F)c12)[C@@H]1O[C@H](COS(N)(=O)=O)[C@@H](O)[C@@H]1F	InChI=1S/C17H16F4N6O5S2/c18-11-12(28)9(5-31-34(23,29)30)32-16(11)27-14-10(13(22)24-6-25-14)15(26-27)33-8-3-1-2-7(4-8)17(19,20)21/h1-4,6,9,11-12,16,28H,5H2,(H2,22,24,25)(H2,23,29,30)/t9-,11+,12-,16-/m1/s1	UFXXZIZZVBXLNM-DFANHVJVSA-N	476103	US10865208, Compound I-158::[(2R,3R,4S,5R)-5-(4-amino-3-{[3-(trifluoromethyl)phenyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-4-fluoro-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476103	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476103&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500848	442076169							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987015	NC(=O)CSc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C12H17N7O6S2/c13-7(21)3-26-12-9-10(14)16-4-17-11(9)19(18-12)8-1-5(20)6(25-8)2-24-27(15,22)23/h4-6,8,20H,1-3H2,(H2,13,21)(H2,14,16,17)(H2,15,22,23)/t5-,6+,8+/m0/s1	UYCRIBDUQLTLLK-SHYZEUOFSA-N	476104	US10865208, Compound I-159::[(2R,3S,5R)-5-{4-amino-3-[(2-amino-2-oxoethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476104	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476104&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295300	442076170							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987016	Nc1ncnc2n(nc(Sc3ccc4CCCc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C19H22N6O5S2/c20-17-16-18(23-9-22-17)25(15-7-13(26)14(30-15)8-29-32(21,27)28)24-19(16)31-12-5-4-10-2-1-3-11(10)6-12/h4-6,9,13-15,26H,1-3,7-8H2,(H2,20,22,23)(H2,21,27,28)/t13-,14+,15+/m0/s1	RJMHDSDUKCLGLF-RRFJBIMHSA-N	476105	US10865208, Compound I-160::{(2R,3S,5R)-5-[4-amino-3-(2,3-dihydro-1H-inden-5-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476105	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476105&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500507	442076171							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987017	Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c(F)c1	InChI=1S/C17H19FN6O5S2/c1-8-2-3-12(9(18)4-8)30-17-14-15(19)21-7-22-16(14)24(23-17)13-5-10(25)11(29-13)6-28-31(20,26)27/h2-4,7,10-11,13,25H,5-6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,11+,13+/m0/s1	GRYCCRMITKNCNZ-DMDPSCGWSA-N	476106	US10865208, Compound I-161::US10865208, Compound I-211::[(2R,3S,5R)-5-{4-amino-3-[(2-fluoro-4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476106&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500761	442076172							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987018	Nc1ncnc2n(nc(SCCO)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C12H18N6O6S2/c13-10-9-11(16-5-15-10)18(17-12(9)25-2-1-19)8-3-6(20)7(24-8)4-23-26(14,21)22/h5-8,19-20H,1-4H2,(H2,13,15,16)(H2,14,21,22)/t6-,7+,8+/m0/s1	PPVHOSLXJQOZMA-XLPZGREQSA-N	476107	US10865208, Compound I-162::[(2R,3S,5R)-5-{4-amino-3-[(2-hydroxyethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476107	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476107&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295285	442076173							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987019	CC(C)(C)c1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1	InChI=1S/C20H26N6O5S2/c1-20(2,3)11-4-6-12(7-5-11)32-19-16-17(21)23-10-24-18(16)26(25-19)15-8-13(27)14(31-15)9-30-33(22,28)29/h4-7,10,13-15,27H,8-9H2,1-3H3,(H2,21,23,24)(H2,22,28,29)/t13-,14+,15+/m0/s1	SYHDADRDFGVLCP-RRFJBIMHSA-N	476108	US10865208, Compound I-163::[(2R,3S,5R)-5-{4-amino-3-[(4-tert-butylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476108	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476108&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295445	442076174							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987020	Nc1ncnc2n(nc(SC3CCC3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C14H20N6O5S2/c15-12-11-13(18-6-17-12)20(19-14(11)26-7-2-1-3-7)10-4-8(21)9(25-10)5-24-27(16,22)23/h6-10,21H,1-5H2,(H2,15,17,18)(H2,16,22,23)/t8-,9+,10+/m0/s1	UYTYFRMKRTZWAC-IVZWLZJFSA-N	476109	US10865208, Compound I-164::{(2R,3S,5R)-5-[4-amino-3-(cyclobutylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476109	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476109&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500751	442076175							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987021	Nc1ncnc2n(nc(SCC(F)F)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C12H16F2N6O5S2/c13-7(14)3-26-12-9-10(15)17-4-18-11(9)20(19-12)8-1-5(21)6(25-8)2-24-27(16,22)23/h4-8,21H,1-3H2,(H2,15,17,18)(H2,16,22,23)/t5-,6+,8+/m0/s1	YUJYQVRWHHVBKK-SHYZEUOFSA-N	476110	US10865208, Compound I-165::[(2R,3S,5R)-5-{4-amino-3-[(2,2-difluoroethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476110	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476110&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			152585623	442076176							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987022	Nc1ncnc2n(nc(Sc3ccc4ccccc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C20H20N6O5S2/c21-18-17-19(24-10-23-18)26(16-8-14(27)15(31-16)9-30-33(22,28)29)25-20(17)32-13-6-5-11-3-1-2-4-12(11)7-13/h1-7,10,14-16,27H,8-9H2,(H2,21,23,24)(H2,22,28,29)/t14-,15+,16+/m0/s1	NROUWFYKUTWUHF-ARFHVFGLSA-N	476111	US10865208, Compound I-166::{(2R,3S,5R)-5-[4-amino-3-(2-naphthylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476111	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476111&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295261	442076177							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987023	Nc1ncnc2n(nc(SC3CC3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C13H18N6O5S2/c14-11-10-12(17-5-16-11)19(18-13(10)25-6-1-2-6)9-3-7(20)8(24-9)4-23-26(15,21)22/h5-9,20H,1-4H2,(H2,14,16,17)(H2,15,21,22)/t7-,8+,9+/m0/s1	VKLLIGJINOTMBT-DJLDLDEBSA-N	476112	US10865208, Compound I-167::{(2R,3S,5R)-5-[4-amino-3-(cyclopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476112	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476112&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500899	442076178							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987024	Nc1ncnc2n(nc(Sc3ccc4CCOc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C18H20N6O6S2/c19-16-15-17(22-8-21-16)24(14-6-11(25)13(30-14)7-29-32(20,26)27)23-18(15)31-10-2-1-9-3-4-28-12(9)5-10/h1-2,5,8,11,13-14,25H,3-4,6-7H2,(H2,19,21,22)(H2,20,26,27)/t11-,13+,14+/m0/s1	LCGDXBNJQIQUGD-IACUBPJLSA-N	476113	US10865208, Compound I-168::{(2R,3S,5R)-5-[4-amino-3-(2,3-dihydro-1-benzofuran-6-ylsulfanyl)-1H- pyrazolo[3,4-d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476113	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476113&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295405	442076179							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987025	Nc1ncnc2n(nc(SC(F)F)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C11H14F2N6O5S2/c12-11(13)25-10-7-8(14)16-3-17-9(7)19(18-10)6-1-4(20)5(24-6)2-23-26(15,21)22/h3-6,11,20H,1-2H2,(H2,14,16,17)(H2,15,21,22)/t4-,5+,6+/m0/s1	IRHPRJHUUCEIBI-KVQBGUIXSA-N	476114	US10865208, Compound I-169::[(2R,3S,5R)-5-{4-amino-3-[(difluoromethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476114	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476114&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295304	442076180							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987026	Nc1ncnc2n(nc(Sc3c[nH]c4ccccc34)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1			476115	US10865208, Compound I-170::{(2R,3S,5R)-5-[4-amino-3-(1H-indol-3-ylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476115	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476115&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500414	442076181							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987027	Nc1ncnc2n(nc(c12)C(F)(F)F)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C11H13F3N6O5S/c12-11(13,14)8-7-9(15)17-3-18-10(7)20(19-8)6-1-4(21)5(25-6)2-24-26(16,22)23/h3-6,21H,1-2H2,(H2,15,17,18)(H2,16,22,23)/t4-,5+,6+/m0/s1	YJFDMVOGTJSYBI-KVQBGUIXSA-N	476116	US10865208, Compound I-171::{(2R,3S,5R)-5-[4-amino-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476116	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476116&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295361	442076182							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987028	CCSc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C12H18N6O5S2/c1-2-24-12-9-10(13)15-5-16-11(9)18(17-12)8-3-6(19)7(23-8)4-22-25(14,20)21/h5-8,19H,2-4H2,1H3,(H2,13,15,16)(H2,14,20,21)/t6-,7+,8+/m0/s1	BCXBJKSUTZHZCN-XLPZGREQSA-N	476117	US10865208, Compound I-172::{(2R,3S,5R)-5-[4-amino-3-(ethylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3- hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476117	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476117&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501139	442076183							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987029	COc1ccc(F)c(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c1	InChI=1S/C17H19FN6O6S2/c1-28-8-2-3-9(18)12(4-8)31-17-14-15(19)21-7-22-16(14)24(23-17)13-5-10(25)11(30-13)6-29-32(20,26)27/h2-4,7,10-11,13,25H,5-6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,11+,13+/m0/s1	GHJYUPXTTAJVPM-DMDPSCGWSA-N	476118	US10865208, Compound I-173::[(2R,3S,5R)-5-{4-amino-3-[(2-fluoro-5-methoxyphenyl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476118	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476118&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295323	442076184							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987030	Nc1ncnc2n(nc(Sc3nccs3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C13H15N7O5S3/c14-10-9-11(18-5-17-10)20(19-12(9)27-13-16-1-2-26-13)8-3-6(21)7(25-8)4-24-28(15,22)23/h1-2,5-8,21H,3-4H2,(H2,14,17,18)(H2,15,22,23)/t6-,7+,8+/m0/s1	CPUVUVDHLPFNAU-XLPZGREQSA-N	476119	US10865208, Compound I-174::{(2R,3S,5R)-5-[4-amino-3-(1,3-thiazol-2-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476119	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476119&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			149943925	442076185							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987031	Nc1ncnc2n(nc(Sc3ccc4OCOc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C17H18N6O7S2/c18-15-14-16(21-6-20-15)23(13-4-9(24)12(30-13)5-29-32(19,25)26)22-17(14)31-8-1-2-10-11(3-8)28-7-27-10/h1-3,6,9,12-13,24H,4-5,7H2,(H2,18,20,21)(H2,19,25,26)/t9-,12+,13+/m0/s1	QVYMHUXTALLLKH-ZWKOPEQDSA-N	476120	US10865208, Compound I-175::{(2R,3S,5R)-5-[4-amino-3-(1,3-benzodioxol-5-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476120	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476120&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151658172	442076186							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987032	Cc1ccccc1Sc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C17H20N6O5S2/c1-9-4-2-3-5-12(9)29-17-14-15(18)20-8-21-16(14)23(22-17)13-6-10(24)11(28-13)7-27-30(19,25)26/h2-5,8,10-11,13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t10-,11+,13+/m0/s1	UWLLOFPIUFOKBK-DMDPSCGWSA-N	476121	US10865208, Compound I-176::[(2R,3S,5R)-5-{4-amino-3-[(2-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476121	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476121&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295224	442076187							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987033	CC(C)(C)Sc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C14H22N6O5S2/c1-14(2,3)26-13-10-11(15)17-6-18-12(10)20(19-13)9-4-7(21)8(25-9)5-24-27(16,22)23/h6-9,21H,4-5H2,1-3H3,(H2,15,17,18)(H2,16,22,23)/t7-,8+,9+/m0/s1	HTHHZLDWKXPSPU-DJLDLDEBSA-N	476122	US10865208, Compound I-177::{(2R,3S,5R)-5-[4-amino-3-(tert-butylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476122	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476122&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500778	442076188							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987034	COc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c(F)c1	InChI=1S/C17H19FN6O6S2/c1-28-8-2-3-12(9(18)4-8)31-17-14-15(19)21-7-22-16(14)24(23-17)13-5-10(25)11(30-13)6-29-32(20,26)27/h2-4,7,10-11,13,25H,5-6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,11+,13+/m0/s1	QWYNGLCKNPKJEE-DMDPSCGWSA-N	476123	US10865208, Compound I-178::[(2R,3S,5R)-5-{4-amino-3-[(2-fluoro-4-methoxyphenyl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476123	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476123&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295245	442076189							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987035	Nc1ncnc2n(nc(Sc3cccc(Cl)c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C16H17ClN6O5S2/c17-8-2-1-3-9(4-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11+,12+/m0/s1	OICGDVPCZSVSCO-QJPTWQEYSA-N	476124	US10865208, Compound I-179::[(2R,3S,5R)-5-{4-amino-3-[(3-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476124	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476124&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295331	442076190							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987036	CN(C)C(=O)CSc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C14H21N7O6S2/c1-20(2)9(23)5-28-14-11-12(15)17-6-18-13(11)21(19-14)10-3-7(22)8(27-10)4-26-29(16,24)25/h6-8,10,22H,3-5H2,1-2H3,(H2,15,17,18)(H2,16,24,25)/t7-,8+,10+/m0/s1	MQQWTMURCBMKAT-QXFUBDJGSA-N	476125	US10865208, Compound I-180::[(2R,3S,5R)-5-(4-amino-3-{[2-(dimethylamino)-2-oxoethyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476125	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476125&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295315	442076191							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987037	CC(C)Sc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C13H20N6O5S2/c1-6(2)25-13-10-11(14)16-5-17-12(10)19(18-13)9-3-7(20)8(24-9)4-23-26(15,21)22/h5-9,20H,3-4H2,1-2H3,(H2,14,16,17)(H2,15,21,22)/t7-,8+,9+/m0/s1	QYDKZZZPZVYXKY-DJLDLDEBSA-N	476126	US10865208, Compound I-181::{(2R,3S,5R)-5-[4-amino-3-(isopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476126	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476126&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501377	442076192							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987038	Nc1ncnc2n(nc(Sc3ccccc3F)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C16H17FN6O5S2/c17-8-3-1-2-4-11(8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-9(24)10(28-12)6-27-30(19,25)26/h1-4,7,9-10,12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t9-,10+,12+/m0/s1	AJJJGLHJXZOKIV-HOSYDEDBSA-N	476127	US10865208, Compound I-182::[(2R,3S,5R)-5-{4-amino-3-[(2-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476127	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476127&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295421	442076193							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987039	Nc1ncnc2n(nc(Sc3ccc4ccccc4n3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C19H19N7O5S2/c20-17-16-18(23-9-22-17)26(15-7-12(27)13(31-15)8-30-33(21,28)29)25-19(16)32-14-6-5-10-3-1-2-4-11(10)24-14/h1-6,9,12-13,15,27H,7-8H2,(H2,20,22,23)(H2,21,28,29)/t12-,13+,15+/m0/s1	WVUNRODDDSHPRF-GZBFAFLISA-N	476128	US10865208, Compound I-183::{(2R,3S,5R)-5-[4-amino-3-(quinolin-2-ylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin- 1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476128	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476128&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295411	442076194							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987040	CC(C)Oc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1	InChI=1S/C19H24N6O6S2/c1-10(2)30-11-3-5-12(6-4-11)32-19-16-17(20)22-9-23-18(16)25(24-19)15-7-13(26)14(31-15)8-29-33(21,27)28/h3-6,9-10,13-15,26H,7-8H2,1-2H3,(H2,20,22,23)(H2,21,27,28)/t13-,14+,15+/m0/s1	QYOLGTLFDIVFPT-RRFJBIMHSA-N	476129	US10865208, Compound I-184::[(2R,3S,5R)-5-{4-amino-3-[(4-isopropoxyphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476129	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476129&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295230	442076195							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987041	CN1C(=O)Cc2cc(Sc3nn([C@H]4C[C@H](O)[C@@H](COS(N)(=O)=O)O4)c4ncnc(N)c34)ccc12	InChI=1S/C19H21N7O6S2/c1-25-11-3-2-10(4-9(11)5-14(25)28)33-19-16-17(20)22-8-23-18(16)26(24-19)15-6-12(27)13(32-15)7-31-34(21,29)30/h2-4,8,12-13,15,27H,5-7H2,1H3,(H2,20,22,23)(H2,21,29,30)/t12-,13+,15+/m0/s1	ZKQUHMJFSOHGIK-GZBFAFLISA-N	476130	US10865208, Compound I-185::[(2R,3S,5R)-5-{4-amino-3-[(1-methyl-2-oxo-2,3-dihydro-1H-indol-5-yl)sulfanyl]- 1H-pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476130	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476130&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295244	442076196							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987042	Nc1ncnc2n(nc(Sc3ccc4OCCc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C18H20N6O6S2/c19-16-15-17(22-8-21-16)24(14-6-11(25)13(30-14)7-29-32(20,26)27)23-18(15)31-10-1-2-12-9(5-10)3-4-28-12/h1-2,5,8,11,13-14,25H,3-4,6-7H2,(H2,19,21,22)(H2,20,26,27)/t11-,13+,14+/m0/s1	MJXWQXHSOUXCNS-IACUBPJLSA-N	476131	US10865208, Compound I-186::{(2R,3S,5R)-5-[4-amino-3-(2,3-dihydro-1-benzofuran-5-ylsulfanyl)-1H- pyrazolo[3,4-d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476131	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476131&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295351	442076197							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987043	Nc1ncnc2n(nc(Sc3ccc(F)cc3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C16H17FN6O5S2/c17-8-1-3-9(4-2-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11+,12+/m0/s1	DVBGRGPNKCSMEL-QJPTWQEYSA-N	476132	US10865208, Compound I-187::[(2R,3S,5R)-5-{4-amino-3-[(4-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476132	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476132&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295449	442076198							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987044	Nc1ncnc2n(nc(SCC#N)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C12H15N7O5S2/c13-1-2-25-12-9-10(14)16-5-17-11(9)19(18-12)8-3-6(20)7(24-8)4-23-26(15,21)22/h5-8,20H,2-4H2,(H2,14,16,17)(H2,15,21,22)/t6-,7+,8+/m0/s1	LKVWAFGXSICJHW-XLPZGREQSA-N	476133	US10865208, Compound I-188::[(2R,3S,5R)-5-{4-amino-3-[(cyanomethyl)sulfanyl]-1H-pyrazolo[3,4-d]pyrimidin- 1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476133	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476133&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500644	442076199							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987045	Nc1ncnc2n(nc(Sc3ccc(Cl)cn3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C15H16ClN7O5S2/c16-7-1-2-10(19-4-7)29-15-12-13(17)20-6-21-14(12)23(22-15)11-3-8(24)9(28-11)5-27-30(18,25)26/h1-2,4,6,8-9,11,24H,3,5H2,(H2,17,20,21)(H2,18,25,26)/t8-,9+,11+/m0/s1	GWQUWSKOAWKSLX-IQJOONFLSA-N	476134	US10865208, Compound I-189::[(2R,3S,5R)-5-{4-amino-3-[(5-chloropyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476134	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476134&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295440	442076200							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987046	COc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C11H16N6O6S/c1-21-11-8-9(12)14-4-15-10(8)17(16-11)7-2-5(18)6(23-7)3-22-24(13,19)20/h4-7,18H,2-3H2,1H3,(H2,12,14,15)(H2,13,19,20)/t5-,6+,7+/m0/s1	DVTGWXRMBVVFAV-RRKCRQDMSA-N	476135	US10865208, Compound I-190::[(2R,3S,5R)-5-(4-amino-3-methoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476135	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476135&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500728	442076201							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987047	Cc1ccc(F)c(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c1	InChI=1S/C17H19FN6O5S2/c1-8-2-3-9(18)12(4-8)30-17-14-15(19)21-7-22-16(14)24(23-17)13-5-10(25)11(29-13)6-28-31(20,26)27/h2-4,7,10-11,13,25H,5-6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,11+,13+/m0/s1	QCIKGMWESBPKEG-DMDPSCGWSA-N	476136	US10865208, Compound I-191::[(2R,3S,5R)-5-{4-amino-3-[(2-fluoro-5-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476136	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476136&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295399	442076202							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987048	Nc1ncnc2n(nc(I)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C10H13IN6O5S/c11-8-7-9(12)14-3-15-10(7)17(16-8)6-1-4(18)5(22-6)2-21-23(13,19)20/h3-6,18H,1-2H2,(H2,12,14,15)(H2,13,19,20)/t4-,5+,6+/m0/s1	PURWERDQGTYMKC-KVQBGUIXSA-N	476137	US10865208, Compound I-192::[(2R,3S,5R)-5-(4-amino-3-iodo-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476137	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476137&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			148975401	442076203							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987049	Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1	InChI=1S/C17H20N6O5S2/c1-9-2-4-10(5-3-9)29-17-14-15(18)20-8-21-16(14)23(22-17)13-6-11(24)12(28-13)7-27-30(19,25)26/h2-5,8,11-13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t11-,12+,13+/m0/s1	FOLVWTRUBGSTBX-YNEHKIRRSA-N	476138	US10865208, Compound I-193::[(2R,3S,5R)-5-{4-amino-3-[(4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476138	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476138&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295336	442076204							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987050	Nc1ncnc2n(nc(Sc3ccccn3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C15H17N7O5S2/c16-13-12-14(20-7-19-13)22(21-15(12)28-10-3-1-2-4-18-10)11-5-8(23)9(27-11)6-26-29(17,24)25/h1-4,7-9,11,23H,5-6H2,(H2,16,19,20)(H2,17,24,25)/t8-,9+,11+/m0/s1	JEBJQJWSEHVCEX-IQJOONFLSA-N	476139	US10865208, Compound I-194::{(2R,3S,5R)-5-[4-amino-3-(pyridin-2-ylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476139	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476139&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			150661960	442076205							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987051	Nc1ncnc2n(nc(OC(F)F)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C11H14F2N6O6S/c12-11(13)25-10-7-8(14)16-3-17-9(7)19(18-10)6-1-4(20)5(24-6)2-23-26(15,21)22/h3-6,11,20H,1-2H2,(H2,14,16,17)(H2,15,21,22)/t4-,5+,6+/m0/s1	FOBNRLCTUZWQPI-KVQBGUIXSA-N	476140	US10865208, Compound I-195::{(2R,3S,5R)-5-[4-amino-3-(difluoromethoxy)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476140	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476140&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501109	442076206							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987052	Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1C	InChI=1S/C18H22N6O5S2/c1-9-3-4-11(5-10(9)2)30-18-15-16(19)21-8-22-17(15)24(23-18)14-6-12(25)13(29-14)7-28-31(20,26)27/h3-5,8,12-14,25H,6-7H2,1-2H3,(H2,19,21,22)(H2,20,26,27)/t12-,13+,14+/m0/s1	PKSCGOBKOIFTGB-BFHYXJOUSA-N	476141	US10865208, Compound I-196::[(2R,3S,5R)-5-{4-amino-3-[(3,4-dimethylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476141	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476141&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295426	442076207							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987053	Nc1ncnc2n(nc(Sc3ccc(OC(F)(F)F)cc3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C17H17F3N6O6S2/c18-17(19,20)32-8-1-3-9(4-2-8)33-16-13-14(21)23-7-24-15(13)26(25-16)12-5-10(27)11(31-12)6-30-34(22,28)29/h1-4,7,10-12,27H,5-6H2,(H2,21,23,24)(H2,22,28,29)/t10-,11+,12+/m0/s1	JVWCPZODDJAGHX-QJPTWQEYSA-N	476142	US10865208, Compound I-197::[(2R,3S,5R)-5-(4-amino-3-{[4-(trifluoromethoxy)phenyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476142	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476142&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295410	442076208							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987054	Nc1ncnc2n(nc(Sc3cccc(OC(F)(F)F)c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C17H17F3N6O6S2/c18-17(19,20)32-8-2-1-3-9(4-8)33-16-13-14(21)23-7-24-15(13)26(25-16)12-5-10(27)11(31-12)6-30-34(22,28)29/h1-4,7,10-12,27H,5-6H2,(H2,21,23,24)(H2,22,28,29)/t10-,11+,12+/m0/s1	UVMWHEAFGOZAPV-QJPTWQEYSA-N	476143	US10865208, Compound I-198::[(2R,3S,5R)-5-(4-amino-3-{[3-(trifluoromethoxy)phenyl]sulfanyl}-1H- pyrazolo[3,4-d]pyrimidin-1-yl)-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476143	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476143&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295297	442076209							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987055	COc1cccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c1	InChI=1S/C17H20N6O6S2/c1-27-9-3-2-4-10(5-9)30-17-14-15(18)20-8-21-16(14)23(22-17)13-6-11(24)12(29-13)7-28-31(19,25)26/h2-5,8,11-13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t11-,12+,13+/m0/s1	WNUULHMTCIVMEF-YNEHKIRRSA-N	476144	US10865208, Compound I-199::[(2R,3S,5R)-5-{4-amino-3-[(3-methoxyphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476144	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476144&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295450	442076210							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987056	CSc1nn([C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C11H16N6O5S2/c1-23-11-8-9(12)14-4-15-10(8)17(16-11)7-2-5(18)6(22-7)3-21-24(13,19)20/h4-7,18H,2-3H2,1H3,(H2,12,14,15)(H2,13,19,20)/t5-,6+,7+/m0/s1	PEIYQDSNKNROMJ-RRKCRQDMSA-N	476145	US10865208, Compound I-200::{(2R,3S,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476145	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476145&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500401	442076211							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987057	Nc1ncnc2n(nc(Sc3ccc4OCCOc4c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C18H20N6O7S2/c19-16-15-17(22-8-21-16)24(14-6-10(25)13(31-14)7-30-33(20,26)27)23-18(15)32-9-1-2-11-12(5-9)29-4-3-28-11/h1-2,5,8,10,13-14,25H,3-4,6-7H2,(H2,19,21,22)(H2,20,26,27)/t10-,13+,14+/m0/s1	DKOFOAFZZREFSH-ZLKJLUDKSA-N	476146	US10865208, Compound I-201::{(2R,3S,5R)-5-[4-amino-3-(2,3-dihydro-1,4-benzodioxin-6-ylsulfanyl)-1H- pyrazolo[3,4-d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 35							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476146	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476146&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295408	442076212							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987058	Nc1ncnc2n(nc(SCC3CC3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C14H20N6O5S2/c15-12-11-13(18-6-17-12)20(19-14(11)26-5-7-1-2-7)10-3-8(21)9(25-10)4-24-27(16,22)23/h6-10,21H,1-5H2,(H2,15,17,18)(H2,16,22,23)/t8-,9+,10+/m0/s1	HAANQVXJGXGBPZ-IVZWLZJFSA-N	476147	US10865208, Compound I-202::[(2R,3S,5R)-5-{4-amino-3-[(cyclopropylmethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476147	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476147&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500531	442076213							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987059	Nc1ncnc2n(nc(Sc3cc4CCCc4cc3F)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C19H21FN6O5S2/c20-11-4-9-2-1-3-10(9)5-14(11)32-19-16-17(21)23-8-24-18(16)26(25-19)15-6-12(27)13(31-15)7-30-33(22,28)29/h4-5,8,12-13,15,27H,1-3,6-7H2,(H2,21,23,24)(H2,22,28,29)/t12-,13+,15+/m0/s1	QJTGKZUDORYAAL-GZBFAFLISA-N	476148	US10865208, Compound I-203::[(2R,3S,5R)-5-{4-amino-3-[(6-fluoro-2,3-dihydro-1H-inden-5-yl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476148	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476148&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500514	442076214							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987060	Nc1ncnc2n(nc(SCc3cc4ccccc4s3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C19H20N6O5S3/c20-17-16-18(23-9-22-17)25(15-6-12(26)13(30-15)7-29-33(21,27)28)24-19(16)31-8-11-5-10-3-1-2-4-14(10)32-11/h1-5,9,12-13,15,26H,6-8H2,(H2,20,22,23)(H2,21,27,28)/t12-,13+,15+/m0/s1	DCWKYZWHMWNPBF-GZBFAFLISA-N	476149	US10865208, Compound I-204::[(2R,3S,5R)-5-{4-amino-3-[(1-benzothiophen-2-ylmethyl)sulfanyl]-1H- pyrazolo[3,4-d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476149	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476149&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295310	442076215							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987061	Cc1cccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c1	InChI=1S/C17H20N6O5S2/c1-9-3-2-4-10(5-9)29-17-14-15(18)20-8-21-16(14)23(22-17)13-6-11(24)12(28-13)7-27-30(19,25)26/h2-5,8,11-13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t11-,12+,13+/m0/s1	GJKSEDOCJGXBNB-YNEHKIRRSA-N	476150	US10865208, Compound I-205::[(2R,3S,5R)-5-{4-amino-3-[(3-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476150	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476150&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295340	442076216							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987062	Nc1ncnc2n(nc(Sc3cccc(F)c3)c12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C16H17FN6O5S2/c17-8-2-1-3-9(4-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11+,12+/m0/s1	QMNBPCZESXAZNB-QJPTWQEYSA-N	476151	US10865208, Compound I-206::[(2R,3S,5R)-5-{4-amino-3-[(3-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476151	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476151&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295325	442076217							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987063	COc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1OC	InChI=1S/C18H22N6O7S2/c1-28-11-4-3-9(5-12(11)29-2)32-18-15-16(19)21-8-22-17(15)24(23-18)14-6-10(25)13(31-14)7-30-33(20,26)27/h3-5,8,10,13-14,25H,6-7H2,1-2H3,(H2,19,21,22)(H2,20,26,27)/t10-,13+,14+/m0/s1	HQWYKJASDLCPTC-ZLKJLUDKSA-N	476152	US10865208, Compound I-207::[(2R,3S,5R)-5-{4-amino-3-[(3,4-dimethoxyphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476152	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476152&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295349	442076218							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987064	Cc1csc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)n1	InChI=1S/C14H17N7O5S3/c1-6-4-27-14(19-6)28-13-10-11(15)17-5-18-12(10)21(20-13)9-2-7(22)8(26-9)3-25-29(16,23)24/h4-5,7-9,22H,2-3H2,1H3,(H2,15,17,18)(H2,16,23,24)/t7-,8+,9+/m0/s1	GXACJNQNAPRWQU-DJLDLDEBSA-N	476153	US10865208, Compound I-208::[(2R,3S,5R)-5-{4-amino-3-[(4-methyl-1,3-thiazol-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476153	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476153&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			150367478	442076219							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987065	Nc1ncnc2n(nc(c12)C(F)(F)F)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C11H13F3N6O5S/c12-11(13,14)8-7-9(15)17-3-18-10(7)20(19-8)6-1-4(21)5(25-6)2-24-26(16,22)23/h3-6,21H,1-2H2,(H2,15,17,18)(H2,16,22,23)/t4-,5-,6+/m0/s1	YJFDMVOGTJSYBI-HCWXCVPCSA-N	476154	US10865208, Compound I-209::{(2S,3S,5R)-5-[4-amino-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]- 3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476154	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476154&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500689	442076220							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987066	Nc1ncnc2n(nc(Sc3ccc4ccccc4c3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C20H20N6O5S2/c21-18-17-19(24-10-23-18)26(16-8-14(27)15(31-16)9-30-33(22,28)29)25-20(17)32-13-6-5-11-3-1-2-4-12(11)7-13/h1-7,10,14-16,27H,8-9H2,(H2,21,23,24)(H2,22,28,29)/t14-,15-,16+/m0/s1	NROUWFYKUTWUHF-HRCADAONSA-N	476155	US10865208, Compound I-210::{(2S,3S,5R)-5-[4-amino-3-(2-naphthylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476155	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476155&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500467	442076221							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987067	Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)c(F)c1	InChI=1S/C17H19FN6O5S2/c1-8-2-3-12(9(18)4-8)30-17-14-15(19)21-7-22-16(14)24(23-17)13-5-10(25)11(29-13)6-28-31(20,26)27/h2-4,7,10-11,13,25H,5-6H2,1H3,(H2,19,21,22)(H2,20,26,27)/t10-,11+,13+/m0/s1	GRYCCRMITKNCNZ-DMDPSCGWSA-N	476106	US10865208, Compound I-161::US10865208, Compound I-211::[(2R,3S,5R)-5-{4-amino-3-[(2-fluoro-4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476106	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476106&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500761	442076172							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987068	CCc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C12H18N6O5S/c1-2-6-10-11(13)15-5-16-12(10)18(17-6)9-3-7(19)8(23-9)4-22-24(14,20)21/h5,7-9,19H,2-4H2,1H3,(H2,13,15,16)(H2,14,20,21)/t7-,8-,9+/m0/s1	OXZOLQCFTQPZCV-XHNCKOQMSA-N	476157	US10865208, Compound I-212::[(2S,3S,5R)-5-(4-amino-3-ethyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476157	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476157&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500544	442076222							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987069	CCSc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C12H18N6O5S2/c1-2-24-12-9-10(13)15-5-16-11(9)18(17-12)8-3-6(19)7(23-8)4-22-25(14,20)21/h5-8,19H,2-4H2,1H3,(H2,13,15,16)(H2,14,20,21)/t6-,7-,8+/m0/s1	BCXBJKSUTZHZCN-BIIVOSGPSA-N	476158	US10865208, Compound I-213::{(2S,3S,5R)-5-[4-amino-3-(ethylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3- hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476158	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476158&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500670	442076223							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987070	Cc1ccc(Sc2nn([C@H]3C[C@H](O)[C@H](COS(N)(=O)=O)O3)c3ncnc(N)c23)cc1	InChI=1S/C17H20N6O5S2/c1-9-2-4-10(5-3-9)29-17-14-15(18)20-8-21-16(14)23(22-17)13-6-11(24)12(28-13)7-27-30(19,25)26/h2-5,8,11-13,24H,6-7H2,1H3,(H2,18,20,21)(H2,19,25,26)/t11-,12-,13+/m0/s1	FOLVWTRUBGSTBX-RWMBFGLXSA-N	476159	US10865208, Compound I-214::[(2S,3S,5R)-5-{4-amino-3-[(4-methylphenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476159	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476159&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			147538678	442076224							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987071	Nc1ncnc2n(nc(Sc3ccccc3F)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C16H17FN6O5S2/c17-8-3-1-2-4-11(8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-9(24)10(28-12)6-27-30(19,25)26/h1-4,7,9-10,12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t9-,10-,12+/m0/s1	AJJJGLHJXZOKIV-JBLDHEPKSA-N	476160	US10865208, Compound I-215::[(2S,3S,5R)-5-{4-amino-3-[(2-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476160	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476160&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295446	442076225							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987072	Nc1ncnc2n(nc(Sc3ccc4CCCc4c3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C19H22N6O5S2/c20-17-16-18(23-9-22-17)25(15-7-13(26)14(30-15)8-29-32(21,27)28)24-19(16)31-12-5-4-10-2-1-3-11(10)6-12/h4-6,9,13-15,26H,1-3,7-8H2,(H2,20,22,23)(H2,21,27,28)/t13-,14-,15+/m0/s1	RJMHDSDUKCLGLF-SOUVJXGZSA-N	476161	US10865208, Compound I-216::{(2S,3S,5R)-5-[4-amino-3-(2,3-dihydro-1H-inden-5-ylsulfanyl)-1H-pyrazolo[3,4- d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476161	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476161&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			151725479	442076226							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987073	Nc1ncnc2n(nc(C(F)F)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C11H14F2N6O5S/c12-9(13)8-7-10(14)16-3-17-11(7)19(18-8)6-1-4(20)5(24-6)2-23-25(15,21)22/h3-6,9,20H,1-2H2,(H2,14,16,17)(H2,15,21,22)/t4-,5-,6+/m0/s1	YJYUGMSUZUYUHW-HCWXCVPCSA-N	476162	US10865208, Compound I-217::{(2S,3S,5R)-5-[4-amino-3-(difluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3- hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476162	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476162&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500719	442076227							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987074	Cc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C11H16N6O5S/c1-5-9-10(12)14-4-15-11(9)17(16-5)8-2-6(18)7(22-8)3-21-23(13,19)20/h4,6-8,18H,2-3H2,1H3,(H2,12,14,15)(H2,13,19,20)/t6-,7-,8+/m0/s1	JQCYYZZBPZNSNR-BIIVOSGPSA-N	476163	US10865208, Compound I-218::[(2S,3S,5R)-5-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476163	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476163&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134501281	442076228							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987075	CSc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C11H16N6O5S2/c1-23-11-8-9(12)14-4-15-10(8)17(16-11)7-2-5(18)6(22-7)3-21-24(13,19)20/h4-7,18H,2-3H2,1H3,(H2,12,14,15)(H2,13,19,20)/t5-,6-,7+/m0/s1	PEIYQDSNKNROMJ-LYFYHCNISA-N	476164	US10865208, Compound I-219::{(2S,3S,5R)-5-[4-amino-3-(methylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3- hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476164	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476164&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500553	442076229							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987076	CC(C)Sc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C13H20N6O5S2/c1-6(2)25-13-10-11(14)16-5-17-12(10)19(18-13)9-3-7(20)8(24-9)4-23-26(15,21)22/h5-9,20H,3-4H2,1-2H3,(H2,14,16,17)(H2,15,21,22)/t7-,8-,9+/m0/s1	QYDKZZZPZVYXKY-XHNCKOQMSA-N	476165	US10865208, Compound I-220::{(2S,3S,5R)-5-[4-amino-3-(isopropylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1- yl]-3-hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476165	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476165&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500781	442076230							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987077	Nc1ncnc2n(nc(SCc3ccccc3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C17H20N6O5S2/c18-15-14-16(21-9-20-15)23(22-17(14)29-8-10-4-2-1-3-5-10)13-6-11(24)12(28-13)7-27-30(19,25)26/h1-5,9,11-13,24H,6-8H2,(H2,18,20,21)(H2,19,25,26)/t11-,12-,13+/m0/s1	AVEMXPARFOSBDP-RWMBFGLXSA-N	476166	US10865208, Compound I-221::{(2S,3S,5R)-5-[4-amino-3-(benzylsulfanyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3- hydroxytetrahydrofuran-2-yl}methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476166	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476166&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500797	442076231							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987078	Nc1ncnc2n(nc(Sc3ccc(Cl)cn3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C15H16ClN7O5S2/c16-7-1-2-10(19-4-7)29-15-12-13(17)20-6-21-14(12)23(22-15)11-3-8(24)9(28-11)5-27-30(18,25)26/h1-2,4,6,8-9,11,24H,3,5H2,(H2,17,20,21)(H2,18,25,26)/t8-,9-,11+/m0/s1	GWQUWSKOAWKSLX-ATZCPNFKSA-N	476167	US10865208, Compound I-222::[(2S,3S,5R)-5-{4-amino-3-[(5-chloropyridin-2-yl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 75							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476167	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476167&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295265	442076232							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987079	Nc1ncnc2n(nc(Sc3ccc(F)cc3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C16H17FN6O5S2/c17-8-1-3-9(4-2-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11-,12+/m0/s1	DVBGRGPNKCSMEL-SDDRHHMPSA-N	476168	US10865208, Compound I-223::[(2S,3S,5R)-5-{4-amino-3-[(4-fluorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476168	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476168&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295312	442076233							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987080	Nc1ncnc2n(nc(Sc3cccc(Cl)c3)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C16H17ClN6O5S2/c17-8-2-1-3-9(4-8)29-16-13-14(18)20-7-21-15(13)23(22-16)12-5-10(24)11(28-12)6-27-30(19,25)26/h1-4,7,10-12,24H,5-6H2,(H2,18,20,21)(H2,19,25,26)/t10-,11-,12+/m0/s1	OICGDVPCZSVSCO-SDDRHHMPSA-N	476169	US10865208, Compound I-224::[(2S,3S,5R)-5-{4-amino-3-[(3-chlorophenyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476169	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476169&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295268	442076234							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987081	COc1nn([C@H]2C[C@H](O)[C@H](COS(N)(=O)=O)O2)c2ncnc(N)c12	InChI=1S/C11H16N6O6S/c1-21-11-8-9(12)14-4-15-10(8)17(16-11)7-2-5(18)6(23-7)3-22-24(13,19)20/h4-7,18H,2-3H2,1H3,(H2,12,14,15)(H2,13,19,20)/t5-,6-,7+/m0/s1	DVTGWXRMBVVFAV-LYFYHCNISA-N	476170	US10865208, Compound I-225::[(2S,3S,5R)-5-(4-amino-3-methoxy-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476170	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476170&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500455	442076235							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987082	Nc1ncnc2n(ncc12)[C@H]1C[C@H](O)[C@@H](COS(N)(=O)=O)O1	InChI=1S/C10H14N6O5S/c11-9-5-2-15-16(10(5)14-4-13-9)8-1-6(17)7(21-8)3-20-22(12,18)19/h2,4,6-8,17H,1,3H2,(H2,11,13,14)(H2,12,18,19)/t6-,7+,8+/m0/s1	RTFNMQRUCBSQQW-XLPZGREQSA-N	476171	US10865208, Compound I-226::[(2S,3S,5R)-5-(4-amino-1H-pyrazolo[3,4-d]pyrimidin-1-yl)-3- hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		>500							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476171	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476171&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			153295397	442076236							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																																		
987083	Nc1ncnc2n(nc(SCC(F)F)c12)[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1	InChI=1S/C12H16F2N6O5S2/c13-7(14)3-26-12-9-10(15)17-4-18-11(9)20(19-12)8-1-5(21)6(25-8)2-24-27(16,22)23/h4-8,21H,1-3H2,(H2,15,17,18)(H2,16,22,23)/t5-,6-,8+/m0/s1	YUJYQVRWHHVBKK-VMHSAVOQSA-N	476172	US10865208, Compound I-227::[(2S,3S,5R)-5-{4-amino-3-[(2,2-difluoroethyl)sulfanyl]-1H-pyrazolo[3,4- d]pyrimidin-1-yl}-3-hydroxytetrahydrofuran-2-yl]methyl sulfamate	Ubiquitin-like modifier-activating enzyme ATG7	Homo sapiens		 300							US Patent		10.7270/Q23B6366		aid1805105	US10865208	Adhikari, S; Calderwood, EF; England, DB; Gould, AE; Harrison, SJ; Huang, S; Ma, L	12/15/2020	7/18/2021	MILLENNIUM PHARMACEUTICALS, INC.	http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=476172	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50006336&target=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search	http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=476172&enzyme=Ubiquitin-like+modifier-activating+enzyme+ATG7&column=ki&startPg=0&Increment=50&submit=Search			134500756	442076237							1	MAAATGDPGLSKLQFAPFSSALDVGFWHELTQKKLNEYRLDEAPKDIKGYYYNGDSAGLPARLTLEFSAFDMSAPTPARCCPAIGTLYNTNTLESFKTADKKLLLEQAANEIWESIKSGTALENPVLLNKFLLLTFADLKKYHFYYWFCYPALCLPESLPLIQGPVGLDQRFSLKQIEALECAYDNLCQTEGVTALPYFLIKYDENMVLVSLLKHYSDFFQGQRTKITIGVYDPCNLAQYPGWPLRNFLVLAAHRWSSSFQSVEVVCFRDRTMQGARDVAHSIIFEVKLPEMAFSPDCPKAVGWEKNQKGGMGPRMVNLSECMDPKRLAESSVDLNLKLMCWRLVPTLDLDKVVSVKCLLLGAGTLGCNVARTLMGWGVRHITFVDNAKISYSNPVRQPLYEFEDCLGGGKPKALAAADRLQKIFPGVNARGFNMSIPMPGHPVNFSSVTLEQARRDVEQLEQLIESHDVVFLLMDTRESRWLPAVIAASKRKLVINAALGFDTFVVMRHGLKKPKQQGAGDLCPNHPVASADLLGSSLFANIPGYKLGCYFCNDVVAPGDSTRDRTLDQQCTVSRPGLAVIAGALAVELMVSVLQHPEGGYAIASSSDDRMNEPPTSLGLVPHQIRGFLSRFDNVLPVSLAFDKCTACSSKVLDQYEREGFNFLAKVFNSSHSFLEDLTGLTLLHQETQAAEIWDMSDDETI		Ubiquitin-like modifier-activating enzyme ATG7	ATG7_HUMAN	O95352	B4E170 E9PB95 Q7L8L0 Q9BWP2 Q9UFH4